| |
|
HBV | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
|
|
| |
| 3. | Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019 |
| |
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):961-966. doi: 10.15585/mmwr.mm7027a1.
Danae Bixler, Pallavi Annambhotla, Martha P Montgomery, Tonya Mixon-Hayden, Ben Kupronis, Marian G Michaels, Ricardo M La Hoz, Sridhar V Basavaraju, Saleem Kamili, Anne Moorman
|
|
| |
|
|
| |
| 5. | Family imaginaries in the disclosure of a blood-borne virus |
| |
Sociol Health Illn. 2021 Jun 23. doi: 10.1111/1467-9566.13316. Online ahead of print.
Anthony K J Smith 1, Asha Persson 1, Kerryn Drysdale 1 2, Joanne Bryant 1, Kylie Valentine 3, Jack Wallace 4, Myra Hamilton 5, Rebecca M Gray 1, Christy E Newman 1
|
|
| |
| 6. | Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study |
| |
BMC Infect Dis. 2021 Jun 26;21(1):610. doi: 10.1186/s12879-021-06226-0.
Tingyan Wang 1 2, David A Smith 2 3, Cori Campbell 1 2, Jolynne Mokaya 1, Oliver Freeman 2 4, Hizni Salih 2 4, Anna L McNaughton 1, Sarah Cripps 5, Kinga A Várnai 2 3, Theresa Noble 2 3, Kerrie Woods 2 3, Jane Collier 6, Katie Jeffery 7, Jim Davies 2 8, Eleanor Barnes # 9 10, Philippa C Matthews # 11 12 13
|
|
| |
|
|
| |
| 8. | Comparison of Novel Biomarkers with Conventional HBV Markers among Untreated Adults with Chronic Hepatitis B in North America |
| |
Hepatology. 2021 Jun 16. doi: 10.1002/hep.32018. Online ahead of print.
Marc G Ghany 1, Wendy C King 2, Mauricio Lisker-Melman 3, Anna Sf Lok 4, Norah Terrault 5, Harry L A Janssen 6, Mandana Khalili 7, Raymond T Chung 8, William M Lee 9, Daryl T Y Lau 10, Gavin A Cloherty 11, Richard K Sterling 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 14. | Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study |
| |
BMC Public Health. 2021 May 28;21(1):1004. doi: 10.1186/s12889-021-11093-0.
Catherine Freeland 1 2, Sean Farrell 3 4, Priyanka Kumar 3 5, Maureen Kamischke 6, Michaela Jackson 6, Sierra Bodor 6, Timothy M Block 6, Rosemary Frasso 3, Chari Cohen 6
|
|
| |
| 15. | An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States |
| |
Hepatology. 2021 Mar 3. doi: 10.1002/hep.31782. Online ahead of print.
Robert J Wong 1 2, Carol L Brosgart 3, Sue Welch 4, Tim Block 5 6, Mark Chen 4, Chari Cohen 5 6, W Ray Kim 1, Kris V Kowdley 7, Anna S Lok 8, Naoky Tsai 9, John Ward 10, Steven S Wong 4, Robert G Gish 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 20. | Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C |
| |
J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13545. Online ahead of print.
Erika Duffell 1, Helena Cortez-Pinto 2, Marieta Simonova 3, Olav Dalgard 4, Elin Hoffmann Dahl 5, Catherine de Martel 6, Antons Mozalevskis 7, Maria Buti 8, Slava Pavlova 3, Tnaiq Hadzhilova 3, Carolina Simões 2, Krum Katzarov 3, Otilia Mardh 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 28. | Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity |
| |
Mol Ther Methods Clin Dev. 2021 Mar 23;21:288-298. doi:10.1016/j.omtm.2021.03.012.eCollection 2021 Jun 11.
Gounwa Awad 1, Toralf Roch 1 2, Ulrik Stervbo 1, Sviatlana Kaliszczyk 1 2, Anna Stittrich 2 3, Jan Hörstrup 4, Ocan Cinkilic 5, Heiner Appel 6, Larysa Natrus 7, Ludmila Gayova 7, Felix Seibert 1, Frederic Bauer 1, Timm Westhoff 1, Mikalai Nienen 2 3 8, Nina Babel 1 2
|
|
| |
|
|
| |
| 30. | Clinical Significance of Quantitative e Antigen in a Cohort of Hepatitis B Virus Infected Children and Adults in North America |
| |
J Viral Hepat. 2021 Apr 24. doi: 10.1111/jvh.13520. Online ahead of print.
Stewart L Cooper 1, Wendy C King 2, Douglas B Mogul 3, Marc G Ghany 4, Kathleen B Schwarz 3, Hepatitis B Research Network (HBRN)
- Hepatitis B Research Network (HBRN):
Daryl T-Y Lau, Raymond T Chung, Lewis R Roberts, Mohamed A Hassan, Sarah Jane Schwarzenberg, Adrian M Di Bisceglie, Mauricio Lisker-Melman, Jeffrey Teckman, Harry L A Janssen, David K Wong, Joshua Juan, Jordan Feld, Colina Yim, Keyur Patel, Simon C Ling, William M Lee, Carol S Murakami, Robert Perrillo, Son Do, Norberto Rodriguez-Baez, Steven-Huy B Han, Tram T Tran, Norah A Terrault, Mandana Khalili, Philip Rosenthal, Anna Suk-Fong Lok, Robert J Fontana, Naoky Tsai, Barak Younoszai, Michael W Fried, Andrew Muir, Donna Evon, Jama M Darling, Robert C Carithers, Margaret Shuhart, Kris V Kowdley, Chia C Wang, Karen F Murray, Richard K Sterling, Velimir A Luketic, T Jake Liang, Jay H Hoofnagle, Edward Doo, Kyong-Mi Chang, Jang-June Park, Steven H Belle, Abdus Wahed, David Kleiner
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 37. | Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B |
| |
J Viral Hepat. 2021 Mar 22. doi: 10.1111/jvh.13499. Online ahead of print.
Gerrit Post 1, Jess Howell 2, Amina Sow 3, Gibril Ndow 4, Isabelle Chemin 5, Gora Lo 3, Amie Cessay 4, Damien Cohen 5, Ramou Njie 6, Souleymane Toure 7, Madoky Diop 7, Roger Sombie 8, Jean Nana 9, Vincent Leroy 9, Karine Lacombe 10, Lamin Bojang 4, Frank Tacke 1, Coumba Toure-Kane 3, Mourtalla Ka 7, Maimuna Mendy 6, Souleymane Mboup 3, Mark Thursz 11, Yusuke Shimakawa 12, Patrick Ingiliz 1 13, Maud Lemoine 11
|
|
| |
| 38. | A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America |
| |
Hepatology. 2021 Mar 20. doi: 10.1002/hep.31823. Online ahead of print.
Richard K Sterling 1, Wendy C King 2, Mandana Khalili 3, Raymond T Chung 4, Mark Sulkowski 5, Mamta K Jain 6, Mauricio Lisker-Melman 7, Marc G Ghany 8, David K Wong 9, Amanda S Hinerman 2, Atul K Bhan 4, Abdus S Wahed 2, David E Kleiner 8, HIV-HBV Cohort Study of the Hepatitis B Research Network
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 42. | Multicenter Evaluation of the Cepheid Xpert ® HBV Viral Load Test |
| |
Diagnostics (Basel). 2021 Feb 12;11(2):297. doi: 10.3390/diagnostics11020297.
Fabbio Marcuccilli 1, Stephane Chevaliez 2, Thomas Muller 3, Luna Colagrossi 4, Giulia Abbondanza 1, Kurt Beyser 3, Mélanie Wlassow 2, Valérie Ortonne 2, Carlo Federico Perno 4, Marco Ciotti 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 48. | The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018 |
| |
Sex Transm Dis. 2021 Jan 23. doi: 10.1097/OLQ.0000000000001380. Online ahead of print.
Harrell W Chesson 1, Ian H Spicknall, Adrienna Bingham, Marc Brisson, Samuel T Eppink, Paul G Farnham, Kristen M Kreisel, Sagar Kumar, Jean-François Laprise, Thomas A Peterman, Henry Roberts, Thomas L Gift
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 54. | Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD) |
| |
NPJ Vaccines. 2021 Jan 11;6(1):9. doi: 10.1038/s41541-020-00266-4.
Shivali S Joshi 1, Rachelle P Davis 2, Mang M Ma 3, Edward Tam 4, Curtis L Cooper 5, Alnoor Ramji 6, Erin M Kelly 5, Saumya Jayakumar 1 7, Mark G Swain 1, Craig N Jenne 2, Carla S Coffin 8
|
|
| |
|
|
| |
|
|
| |
| 57. | Adherence to pregnancy hepatitis B care guidelines in women and infants in the and evaluation of two interventions to improve care: a multi-center hospital-based study |
| |
J Viral Hepat. 2020 Dec 29. doi: 10.1111/jvh.13459. Online ahead of print.
Tatyana Kushner 1, Elianna Kaplowitz 2, Rena Mei 3, Chelsea Xu 4, Alex Acker 5, Emma Rosenbluth 1, Igbagbosanmi Oredein 4, Monika Sarkar 4, Norah Terrault 6, Meena Bansal 1, Kimberly A Forde 7 8
|
|
| |
|
|
| |
| 59. | Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement |
| |
JAMA. 2020 Dec 15;324(23):2415-2422. doi: 10.1001/jama.2020.22980.
US Preventive Services Task Force; Alex H Krist 1 2, Karina W Davidson 3, Carol M Mangione 4, Michael J Barry 5, Michael Cabana 6, Aaron B Caughey 7, Katrina Donahue 8, Chyke A Doubeni 9, John W Epling Jr 10, Martha Kubik 11, Gbenga Ogedegbe 12, Douglas K Owens 13, Lori Pbert 14, Michael Silverstein 15, Melissa A Simon 16, Chien-Wen Tseng 17 18, John B Wong 19
|
|
| |
|
|
| |
| 61. | New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings |
| |
J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):98-103. doi: 10.1097/QAI.0000000000002517.
David Dunn 1 2, Huw Price 1, Tobias Vudriko 3, Cissy Kityo 4, Godfrey Musoro 5, James Hakim 5, Charles Gilks 6, Pontiano Kaleebu 3, Deenan Pillay 7, Richard Gilson 1, DART Virology Group
|
|
| |
| 62. | Distinct Hepatitis B and HIV co-infected populations in Canada |
| |
J Viral Hepat. 2020 Dec 11. doi: 10.1111/jvh.13453. Online ahead of print.
Curtis Cooper 1, Matt Driedger 1, David Wong 2, Sarah Haylock-Jacobs 3, Abdel Aziz Shaheen 3, Carla Osiowy 4, Scott Fung 2, Karen Doucette 5, Alexander Wong 6, Lisa Barrett 7, Brian Conway 8, Alnoor Ramji 9, Gerald Minuk, Giada Sebastiani, Philip Wong, Carla S Coffin 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 68. | Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis |
| |
Drug Saf. 2020 Nov 3. doi: 10.1007/s40264-020-01014-2. Online ahead of print.
William R Treem 1, Melissa Palmer 2 3, Isabelle Lonjon-Domanec 4, Daniel Seekins 5, Lara Dimick-Santos 6, Mark I Avigan 6, John F Marcinak 7, Ajit Dash 8, Arie Regev 9, Eric Maller 10 11, Meenal Patwardhan 7, James H Lewis 12, Don C Rockey 13, Adrian M Di Bisceglie 14, James W Freston 15, Raul J Andrade 16, Naga Chalasani 17
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 75. | Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes |
| |
Open Forum Infect Dis. 2020 Aug 13;7(9):ofaa347. doi: 10.1093/ofid/ofaa347.eCollection 2020 Sep.
Zahid A Butt 1 2 3, Stanley Wong 2, Carmine Rossi 2, Mawuena Binka 2, Jason Wong 2 3, Amanda Yu 2, Maryam Darvishian 4, Maria Alvarez 2, Nuria Chapinal 4, Geoff Mckee 2, Mark Gilbert 2 3, Mark W Tyndall 3, Mel Krajden 2 3 5, Naveed Z Janjua 2 3
|
|
| |
|
|
| |
| 77. | A global investment framework for the elimination of hepatitis B |
| |
J Hepatol. 2020 Sep 21;S0168-8278(20)33625-4. doi: 10.1016/j.jhep.2020.09.013.Online ahead of print.
Jessica Howell 1, Alisa Pedrana 2, Sophia E Schroeder 2, Nick Scott 2, Lisa Aufegger 3, Rifat Atun 4, Ricardo Baptista-Leite 5, Gottfried Hirnschal 6, Ellen 't Hoen 7, Sharon J Hutchinson 8, Jeffrey V Lazarus 9, Lesi Olufunmilayo 10, Raquel Peck 11, Manik Sharma 12, Annette H Sohn 13, Alexander Thompson 14, Mark Thursz 15, David Wilson 2, Margaret Hellard 16
|
|
| |
|
|
| |
| 79. | medLow Incidence of Adverse Outcomes in Adults with Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy |
| |
Hepatology. 2020 Sep 16.doi: 10.1002/hep.31554. Online ahead of print.
Anna S Lok 1, Robert Perrillo 2, Christina M Lalama 3, Michael W Fried 4, Steven H Belle 5, Marc G Ghany 6, Mandana Khalili 7, Robert J Fontana 1, Richard K Sterling 8, Norah Terrault 9, Jordan J Feld 10, Adrian M Di Bisceglie 11, Daryl T Y Lau 12, Mohamed Hassan 13, Harry L A Janssen 14, Hepatitis B Research Network (HBRN)
Collaborators
- Hepatitis B Research Network (HBRN):
Raymond T Chung, Lewis R Roberts, Mauricio Lisker-Melman, David K Wong, Joshua Juan, Colina Yim, Keyur Patel, William M Lee, Carol S Murakami, Son Do, Steven-Huy B Han, Tram T Tran, Stewart L Cooper, Naoky Tsai, Barak Younoszai, Andrew Muir, Donna Evon, Jama M Darling, Robert C Carithers, Kris V Kowdley, Chia C Wang, Velimir A Luketic, T Jake Liang, Jay H Hoofnagle, Edward Doo, Kyong-Mi Chang, Jang-June Park, Abdus Wahed, Wendy C King, David Kleiner
|
|
| |
| 80. | Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort Study |
| |
Open Forum Infect Dis. 2019 Nov 3;6(11):ofz469. doi: 10.1093/ofid/ofz469.eCollection 2019 Nov.
Jane Davies 1 2, Emma L Smith 2, Margaret Littlejohn 3, Rosalind Edwards 3, Vitina Sozzi 3, Kathy Jackson 3, Katie Mcguire 1, Paula Binks 1, Benjamin C Cowie 4 5, Stephen Locarnini 3, Joshua S Davis 1 6, Steven Y C Tong 1 7 8
|
|
| |
|
|
| |
|
|
| |
| 83. | Improving uptake of hepatitis B and hepatitis C testing in South Asian migrants in community and faith settings using educational interventions - a prospective descriptive study |
| |
Int J Infect Dis. 2020 Aug 27;S1201-9712(20)30689-5. doi: 10.1016/j.ijid.2020.08.059.Online ahead of print.
Claire Kelly 1, Marinos Pericleous 1, Ayesha Ahmed 2, Tushna Vandrevala 3, Jane Hendy 2, Shuja Shafi 4, Simon Skene 5, Sumita Verma 6, Chantal Edge 7, Margot Nicholls 8, Charles Gore 9, Simon de Lusignan 10, Aftab Ala 11
|
|
| |
| 84. | Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis |
| |
Aliment Pharmacol Ther. 2020 Sep 4. doi: 10.1111/apt.16067. Online ahead of print.
Milan J Sonneveld 1, Willem P Brouwer 1, Bettina E Hansen 2, Henry L-Y Chan 3, Teerha Piratvisuth 4, Ji-Dong Jia 5, Stefan Zeuzem 6, Rong-Nan Chien 7, Hannah Choi 2, Robert J de Knegt 1, Cynthia Wat 8, Vedran Pavlovic 8, Anuj Gaggar 9, Qing Xie 10, Maria Buti 11, Robert A de Man 1, Harry L A Janssen 1 2, SONIC-B Study Group
|
|
| |
| 85. | Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection |
| |
Clin Infect Dis. 2020 Sep 1;ciaa1303. doi: 10.1093/cid/ciaa1303. Online ahead of print.
Mandana Khalili 1, Wendy C King 2, David E Kleiner 3, Mamta K Jain 4, Raymond T Chung 5, Mark Sulkowski 6, Mauricio Lisker-Melman 7, David K Wong 8, Marc Ghany 3, Arun Sanyal 9, Richard K Sterling 9, HIV-HBV Cohort Study of the Hepatitis B Research Network
|
|
| |
| 86. | Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS) |
| |
Transfusion. 2020 Aug 31. doi: 10.1111/trf.16005. Online ahead of print.
Whitney R Steele 1, Roger Y Dodd 1, Edward P Notari 1, Meng Xu 1, Diane Nelson 1, Debra A Kessler 2, Rita Reik 3, Alan E Williams 4, Brian Custer 5, Susan L Stramer 1, Transfusion-Transmissible Infections Monitoring System (TTIMS)
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 90. | Susceptibility to Hepatitis A and B Virus Among Clients at a Syringe Services Program in Philadelphia, 2018 |
| |
Public Health Rep. 2020 Aug 13;33354920943528. doi: 10.1177/0033354920943528.Online ahead of print.
Mary Figgatt 1, Jack Hildick-Smith 1, Eman Addish 1, Jennie Coleman 2, José Benitez 2, Catherine Freeland 3, Steven Alles 1, Kendra Viner 1, Caroline Johnson 1, Danica Kuncio 1
|
|
| |
| 91. | New blood borne virus infections among organ transplant recipients: an Australian data-linked cohort study examining donor-transmissions and other HIV, hepatitis C and hepatitis B notifications, 2000-2015 |
| |
Transpl Infect Dis. 2020 Aug 7;e13437. doi: 10.1111/tid.13437. Online ahead of print.
Karen Mj Waller 1, Nicole L De La Mata 1, James A Hedley 1, Brenda M Rosales 1 2, Michael J O'Leary, Elena Cavazzoni 3, Vidiya Ramachandran 4, William D Rawlinson 4 5, Patrick J Kelly 1, Kate R Wyburn 2 6, Angela C Webster 1 7
|
|
| |
|
|
| |
| 93. | Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation |
| |
Hepatology. 2020 Aug 2. doi: 10.1002/hep.31491. Online ahead of print.
Elizabeth C Verna 1, Marina Serper 2, Jaime Chu 3, Kathleen Corey 4, Oren K Fix 5, Karen Hoyt 6, Kimberly A Page 7, Rohit Loomba 8, Ming Li 9, Gregory T Everson 10, Michael W Fried 11, Guadalupe Garcia-Tsao 12, Norah Terrault 9, Anna S Lok 13, Raymond T Chung 4, K Rajender Reddy 2
|
|
| |
| 94. | Hepatitis B Virus Mutant Infections in Hemodialysis Patients: A Case Series |
| |
Kidney Med. 2019 Oct 1;1(6):347-353. doi: 10.1016/j.xkme.2019.07.011.eCollection Nov-Dec 2019.
Ibironke W Apata 1 2, Duc B Nguyen 1, Yury Khudyakov 1, Tonya Mixson-Hayden 1, Jon Rosenberg 3, Matt Zahn 4, Jane Greenko 5, Ernest Clement 6, Allison E Portney 7 8, Prathit A Kulkarni 1 7, Maura Comer 9, Eleanor Adams 10, Saleem Kamili 1, Priti R Patel 1, Anne C Moorman 1
|
|
| |
|
|
| |
| 96. | Progress towards elimination goals for viral hepatitis |
| |
Nat Rev Gastroenterol Hepatol. 2020 Jul 23;1-10. doi: 10.1038/s41575-020-0332-6.Online ahead of print.
Andrea L Cox 1, Manal H El-Sayed 2, Jia-Horng Kao 3 4, Jeffrey V Lazarus 5, Maud Lemoine 6, Anna S Lok 7, Fabien Zoulim 8 9 10
|
|
| |
| 97. | Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide |
| |
Dig Liver Dis. 2020 Jul 20;S1590-8658(20)30322-4. doi: 10.1016/j.dld.2020.06.037.Online ahead of print.
Luisa Roade 1, Alessandro Loglio 2, Marta Borghi 2, Mar Riveiro-Barciela 1, Roberta Soffredini 2, Floriana Facchetti 2, Dhanai di Paolo 2, David Tabernero 3, Giovanna Lunghi 4, Rafael Esteban 1, Maria Buti 5, Pietro Lampertico 6
|
|
| |
|
|
| |
|
|
| |
| 100. | Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategies |
| |
Mil Med. 2020 Jul 10;usaa131. doi: 10.1093/milmed/usaa131. Online ahead of print.
Paul T Scott 1, Robert L Cohen 2 3, David M Brett-Major 4, Shilpa Hakre 1 5, Jennifer A Malia 1, Jason F Okulicz 6, Charmagne G Beckett 7, Jason M Blaylock 8, Michael A Forgione 6, Stephen A Harrison 6, Clinton K Murray 6, Francisco J Rentas 9, Roland L Fahie 9, Adam W Armstrong 10, Aatif M Hayat 2, Laura A Pacha 2 11, Peter Dawson 12, Beth Blackwell 12, Angelia A Eick-Cost 13 14, Hala H Maktabi 13 15, Nelson L Michael 1, Linda L Jagodzinski 1, Steven B Cersovsky 2, Sheila A Peel 1
|
|
| |
|
|
| |
| 102. | ATI-2173, A Novel Liver-Targeted Non-Chain Terminating Nucleotide for HBV Cure Regimens |
| |
Antimicrob Agents Chemother. 2020 Jun 15;AAC.00836-20. doi: 10.1128/AAC.00836-20.Online ahead of print.
Katherine E Squires 1, Douglas L Mayers 1, Gregory R Bluemling 2, Alexander A Kolykhalov 2, David B Guthrie 2, Prabhakar Reddy 2, Debbie G Mitchell 2, Manohar T Saindane 2, Zachary M Sticher 2, Vindhya Edpuganti 2, Abel De La Rosa 1
|
|
| |
| 103. | Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020 |
| |
MMWR Recomm Rep. 2020 Jun 26;69(4):1-16. doi: 10.15585/mmwr.rr6904a1.
Jefferson M Jones, Ian Kracalik, Marilyn E Levi, James S Bowman 3rd, James J Berger, Danae Bixler, Kate Buchacz, Anne Moorman, John T Brooks, Sridhar V Basavaraju
|
|
| |
|
|
| |
|
|
| |
| 106. | Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic HBV Infection: Systematic Review and Meta-analysis |
| |
Clin Gastroenterol Hepatol. 2020 May 27;S1542-3565(20)30748-5.doi: 10.1016/j.cgh.2020.05.041. Online ahead of print.
Ryan T Anderson 1, Hannah S J Choi 2, Oliver Lenz 3, Marion G Peters 4, Harry L A Janssen 5, Poonam Mishra 6, Eric Donaldson 7, Gabriel Westman 8, Stephanie Buchholz 9, Veronica Miller 10, Bettina E Hansen 11
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 115. | Vitamin D and the Hepatitis B Vaccine Response: A Prospective Cohort Study and a Randomized, Placebo-Controlled Oral Vitamin D 3 and Simulated Sunlight Supplementation Trial in Healthy Adults |
| |
Nutr. 2020 May 10.doi: 10.1007/s00394-020-02261-w. Online ahead of print
Daniel S Kashi 1 2, Samuel J Oliver 3, Laurel M Wentz 4, Ross Roberts 1, Alexander T Carswell 1, Jonathan C Y Tang 5, Sarah Jackson 6, Rachel M Izard 7, Donald Allan 8, Lesley E Rhodes 9, William D Fraser 5, Julie P Greeves 5 6, Neil P Walsh 2
|
|
| |
|
|
| |
|
|
| |
| 118. | Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data |
| |
Clin Gastroenterol Hepatol. 2020 Apr 29;S1542-3565(20)30590-5.doi: 10.1016/j.cgh.2020.04.045. Online ahead of print.
Kyoko Yoshida 1, Alice Desbiolles 2, Sarah F Feldman 2, Sang Hoon Ahn 3, Enagnon K Alidjinou 4, Masanori Atsukawa 5, Laurence Bocket 4, Maurizia R Brunetto 6, Maria Buti 7, Ivana Carey 8, Gian Paolo Caviglia 9, En-Qiang Chen 10, Markus Cornberg 11, Masaru Enomoto 12, Masao Honda 13, Christoph Höner Zu Siederdissen 11, Masatoshi Ishigami 14, Harry LA Janssen 15, Benjamin Maasoumy 11, Takeshi Matsui 16, Akihiro Matsumoto 17, Shuhei Nishiguchi 18, Mar Riveiro-Barciela 7, Akinobu Takaki 19, Pisit Tangkijvanich 20, Hidenori Toyoda 21, Margo Jh van Campenhout 22, Bo Wang 8, Lai Wei 23, Hwai-I Yang 24, Yoshihiko Yano 25, Hiroshi Yatsuhashi 26, Man-Fung Yuen 27, Eiji Tanaka 28, Maud Lemoine 1, Yasuhito Tanaka 29, Yusuke Shimakawa 30
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 122. | Hbsag Levels Can Be Used to Rule Out Cirrhosis in Hbeag Positive Chronic Hepatitis B: Results From the Sonic-B Study |
| |
J Infect Dis. 2020 Apr 21;jiaa192 doi: 10.1093/infdis/jiaa192. Online ahead of print.
Milan J Sonneveld 1, Bettina E Hansen 2 3, Willem P Brouwer 1, Henry L-Y Chan 4, Teerha Piratvisuth 5, Ji-Dong Jia 6, Stefan Zeuzem 7, R N Chien 8, R J de Knegt 1, Cynthia Wat 9, Vedran Pavlovic 9, Anuj Gaggar 10, Qing Xie 11, Maria Buti 12, R A de Man 1, Harry L A Janssen 1 2, SONIC-B Study group
|
|
| |
| 123. | Hepatitis B Virus Seroepidemiology Data for Africa: Modelling Intervention Strategies Based on a Systematic Review and Meta-Analysis |
| |
PLoS Med. 2020 Apr 21;17(4):e1003068. doi: 10.1371/journal.pmed.1003068.eCollection 2020 Apr.
Anna L McNaughton 1, José Lourenço 2, Phillip Armand Bester 3, Jolynne Mokaya 1, Sheila F Lumley 1 4, Uri Obolski 5 6, Donall Forde 7, Tongai G Maponga 8, Kenneth R Katumba 9, Dominique Goedhals 3, Sunetra Gupta 2, Janet Seeley 9 10, Robert Newton 9 11, Ponsiano Ocama 12, Philippa C Matthews 1 4
|
|
| |
|
|
| |
|
|
| |
| 126. | Final Analysis of the International Observational S-Collate Study of Peginterferon alfa-2a in Patients With Chronic Hepatitis B |
| |
PloS One. 2020 Apr 10;15(4):e0230893. doi: 10.1371/journal.pone.0230893. eCollection 2020.
Patrick Marcellin 1, Qing Xie 2, Seung Woon Paik 3, Robert Flisiak 4, Teerha Piratvisuth 5, Jörg Petersen 6, Tarik Asselah 1, Markus Cornberg 7, Denis Ouzan 8, Graham R Foster 9, Georgios Papatheodoridis 10, Diethelm Messinger 11, Loredana Regep 12, Georgios Bakalos 13, Ulrich Alshuth 14, Pietro Lampertico 15, Heiner Wedemeyer 7
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 130. | Hepatic Histology in Treatment-naïve Children With Chronic Hepatitis B Infection Living in the United States and Canada |
| |
Rodriguez-Baez N1, Murray KF2, Kleiner DE3, Ling SC4, Rosenthal P5, Carlin K6, Cooper K6, Schwarz KB7, Schwarzenberg SJ8, Teckman JH9, Ghany MG10, Alawad A10. J Pediatr Gastroenterol Nutr. 2020 Apr 3. doi: 10.1097/MPG.0000000000002712. [Epub ahead of print]
|
|
| |
| 131. | Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey |
| |
Mukhtar NA1, Evon DM2, Yim C3, Lok AS4, Lisha N5, Lisker-Melman M6, Hassan M7, Janssen HLA3, Khalili M8. Dig Dis Sci. 2020 Apr 1. doi: 10.1007/s10620-020-06224-3. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 138. | Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease |
| |
Chan TT1, Chan WK2, Wong GL1,3, Chan AW4, Nik Mustapha NR5, Chan SL6, Chong CC7, Mahadeva S2, Shu SS1,3, Lai PB7, Chan HL1,3, Wong VW1,3. Am J Gastroenterol. 2020 Mar 9. doi: 10.14309/ajg.0000000000000588. [Epub ahead of print]
|
|
| |
| 139. | A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B |
| |
Chen Y1,2, Cao D2, Li C1,2, Zhang P1,2, Wang X1, Li N1, Han Q1, Liu Z1. Eur J Gastroenterol Hepatol. 2020 Feb 27. doi: 10.1097/MEG.0000000000001691. [Epub ahead of print]
|
|
| |
| 140. | Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America |
| |
Brahmania M1, Liu S2, Wahed AS3, Yim C1, Hansen BE4, Khalili M5, Terrault NA5, Lok AS6, Ghany M7, Wang J2, Wong D1, Janssen HLA8; Hepatitis B Research Network. Ann Hepatol. 2020 Feb 8. pii: S1665-2681(20)30009-0. doi: 10.1016/j.aohep.2020.01.005. [Epub ahead of print]
|
|
| |
| 141. | No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic HBV Infection Treated With Entecavir vs Tenofovir |
| |
Oh H1, Yoon EL2, Jun DW3, Ahn SB4, Lee HY4, Jeong JY5, Kim HS6, Jeong SW7, Kim SE8, Shim JJ9, Sohn JH10, Cho YK11; Long-term Safety of Entecavir and Tenofovir in Patients with Treatment-naive Chronic Hepatitis B virus (CHB) Infection (SAINT) study. Clin Gastroenterol Hepatol. 2020 Mar 2. pii: S1542-3565(20)30265-2. doi: 10.1016/j.cgh.2020.02.046. [Epub ahead of print]
|
|
| |
| 142. | Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis |
| |
Harigai M1, Winthrop K2, Takeuchi T3, Hsieh TY4, Chen YM4, Smolen JS5, Burmester G6, Walls C7, Wu WS7, Dickson C7, Liao R7, Genovese MC8. RMD Open. 2020 Feb;6(1). pii: e001095. doi: 10.1136/rmdopen-2019-001095
|
|
| |
| 143. | Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis |
| |
Gao X1,2, Yang HI3, Trinh H4, Jeong D1, Li J5, Zhang J6, Le A1, Hoang J1, Nguyen P1, Henry L1, Nguyen MH1. Eur J Gastroenterol Hepatol. 2019 Dec 24. doi: 10.1097/MEG.0000000000001639.
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 161. | Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B |
| |
Lok AS1, Zoulim F2, Dusheiko G3, Chan HLY4, Buti M5, Ghany MG6, Gaggar A7, Yang JC7, Wu G7, Flaherty JF7, Subramanian GM7, Locarnini S8, Marcellin P9. Hepatol Commun. 2019 Oct 10;4(1):8-20. doi: 10.1002/hep4.1436. eCollection 2020 Jan.
|
|
| |
| 162. | Hepatitis B virus RNA as Early Predictor for Response to PEGylated Interferon Alfa in HBeAg Negative Chronic Hepatitis B |
| |
Farag MS1,2, van Campenhout MJH3, Pfefferkorn M4, Fischer J4, Deichsel D4, Boonstra A3, van Vuuren AJ3, Ferenci P5, Feld JJ1, Berg T4, Hansen BE1,6, van Bömmel F4, Janssen HLA1. Clin Infect Dis. 2020 Jan 8. pii: ciaa013. doi: 10.1093/cid/ciaa013. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 165. | Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis |
| |
Li M1, Lv T2, Wu S1, Wei W1, Wu X3, Ou X2, Ma H2, Chow SC4, Kong Y5, You H6, Jia J7. Hepatol Int. 2020 Jan 3. doi: 10.1007/s12072-019-10005-0. [Epub ahead of print]
|
|
| |
| 166. | Enhancing the hepatitis B care cascade in Australia: A cost-effectiveness model |
| |
Xiao Y1,2,3, Howell J1,2,3,4, van Gemert C1,3, Thompson AJ2,3, Seaman CP1,4, McCulloch K3,5,6,7, Scott N1,4, Hellard ME1,3,4,7,8,9. J Viral Hepat. 2019 Dec 19. doi: 10.1111/jvh.13252. [Epub ahead of print]
|
|
| |
| 167. | Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission |
| |
Sarin SK1, Kumar M2, Eslam M3, George J3, Al Mahtab M4, Akbar SMF5, Jia J6, Tian Q6, Aggarwal R7, Muljono DH8, Omata M9, Ooka Y10, Han KH11, Lee HW11, Jafri W12, Butt AS12, Chong CH13, Lim SG14, Pwu RF15, Chen DS16. Lancet Gastroenterol Hepatol. 2019 Dec 13. pii: S2468-1253(19)30342-5. doi: 10.1016/S2468-1253(19)30342-5. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 170. | Role of Biomarkers in Guiding Cure of Viral Hepatitis B |
| |
Buti M1,2, Riveiro-Barciela M1,2, Rodríguez-Frías F2,3,4, Tabernero D2,3, Esteban R1,2. Semin Liver Dis. 2019 Dec 5. doi: 10.1055/s-0039-3401031. [Epub ahead of print]
|
|
| |
| 171. | Role of Biomarkers in Guiding Cure of Viral Hepatitis B |
| |
Buti M1,2, Riveiro-Barciela M1,2, Rodríguez-Frías F2,3,4, Tabernero D2,3, Esteban R1,2. Semin Liver Dis. 2019 Dec 5. doi: 10.1055/s-0039-3401031. [Epub ahead of print]
|
|
| |
| 172. | Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers |
| |
Mahfouz M1, Nguyen H2, Tu J3, Diaz CR4,5, Anjan S6, Brown S4, Bosire K7, Carrasquillo O4,8, Martin P8,9, Jones PD10,11. Dig Dis Sci. 2019 Dec 7. doi: 10.1007/s10620-019-05980-1. [Epub ahead of print]
|
|
| |
| 173. | Liver safety assessment in clinical trials of new agents for chronic hepatitis B |
| |
Fontana RJ1, Avigan MI2, Janssen HLA3, Regev A4, Mishra P5, Gaggar A6, Brown N7, Wat C8, Mendez P9, Anderson RT10, Given B11, Miller V10, Beumont M12. J Viral Hepat. 2019 Dec 11. doi: 10.1111/jvh.13223. [Epub ahead of print]
|
|
| |
|
|
| |
| 175. | Long-term virological and adherence outcomes to antiviral treatment in a 4-year cohort chronic HBV study |
| |
Abreu RM1,2, Bassit LC3, Tao S3, Jiang Y3, Ferreira AS1, Hori PC2, Ganova-Raeva LM4, Khudyakov Y4, Schinazi RF3, Carrilho FJ1, Ono SK1. Antivir Ther. 2019 Dec 4. doi: 10.3851/IMP3338. [Epub ahead of print]
|
|
| |
| 176. | Incidence and Risk Factors of Postoperative Mortality and Morbidity After Elective Versus Emergent Abdominal Surgery in a National Sample of 8193 Patients With Cirrhosis |
| |
Johnson KM1,2, Newman KL3, Green PK4, Berry K4, Cornia PB1,2, Wu P5, Beste LA4,6,2, Itani K7, Harris AHS8,9, Kamath PS10, Ioannou GN4,11. Ann Surg. 2019 Oct 23. doi: 10.1097/SLA.0000000000003674. [Epub ahead of print]
|
|
| |
|
|
| |
| 178. | Point of care and oral fluid Hepatitis B testing in remote Indigenous communities of northern Australia |
| |
Sullivan RP1,2,3, Davies J1,2, Binks P1, Dhurrkay RG1, Gurruwiwi GG1, Bukulatjpi SM1, McKinnon M1, Hosking K1,4, Littlejohn M5, Jackson K5, Locarnini S5, Davis JS1,6, Tong SY1,7. J Viral Hepat. 2019 Nov 29. doi: 10.1111/jvh.13243. [Epub ahead of print]
|
|
| |
| 179. | Asian Consensus Recommendations on Optimizing the Diagnosis and Initiation of Treatment of Hepatitis B Virus Infection in Resource-Limited Settings |
| |
Gane EJ1, Charlton MR2, Mohamed R3, Sollano JD4, Tun KS5, Thuy PTT6, Payawal DA7, Gani RA8, Muljono DH9,10,11, Acharya SK12, Zhuang H13, Shukla A14, Madan K15, Saraf N16, Tyagi S17, Singh KR18, Cua IHY19, Jargalsaikhan G20,21, Duger D22, Sukeepaisarnjaroen W23, Purnomo HD24, Hasan I25, Lesmana LA26, Lesmana CRA27, Kyi KP28, Naing W29, Ac R30, Hadigal S30. J Viral Hepat. 2019 Nov 30. doi: 10.1111/jvh.13244. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 184. | RNA Interference Therapy with ARC-520 Results in Prolonged HBsAg Response in Patients with Chronic Hepatitis B Infection |
| |
Yuen MF1, Schiefke I2, Yoon JH3, Ahn SH4, Heo J5, Kim JH6, Chan HLY7, Yoon KT8, Klinker H9, Manns M10, Petersen J11, Schluep T12, Hamilton J12, Given BD12, Ferrari C13, Lai CL1, Locarnini SA14, Gish RG15. Hepatology. 2019 Oct 26. doi: 10.1002/hep.31008. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 187. | 'Teach-back' is a simple communication tool that improves disease knowledge in people with chronic hepatitis B - a pilot randomized controlled study |
| |
Tran S1,2, Bennett G3,4, Richmond J3,4,5, Nguyen T3,4, Ryan M3,4, Hong T3,4, Howell J3,4, Demediuk B3,4, Desmond P3,4, Bell S3,4, Thompson A6,7. BMC Public Health. 2019 Oct 23;19(1):1355. doi: 10.1186/s12889-019-7658-4.
|
|
| |
|
|
| |
| 189. | Long-term Outcomes with Oral Therapy in Liver Transplant Recipients with Hepatitis B |
| |
Saab S1,2,3, Song D2, Challita YP1, Zhou TX1, Saab EG1, Viramontes MR1, Choi G1,2, Durazo FA1,2, Han SB1,2, El Kabany MM1,2, Jackson NJ4, Busuttil RW1. Clin Transplant. 2019 Oct 25:e13740. doi: 10.1111/ctr.13740. [Epub ahead of print]
|
|
| |
| 190. | National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018 |
| |
Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, Singleton JA, Stokley S. MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):718-723. doi: 10.15585/mmwr.mm6833a2.
|
|
| |
|
|
| |
| 192. | HIV and the liver |
| |
Sherman KE1, Peters MG2, Thomas DL3. Top Antivir Med. 2019 Sep/Oct;27(3):101-110.
|
|
| |
| 193. | Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis |
| |
Platt L1, French CE2, McGowan CR1,3, Sabin K4, Gower E5, Trickey A2, McDonald B6,7, Ong J7, Stone J2, Easterbrook P8, Vickerman P2. J Viral Hepat. 2019 Oct 11. doi: 10.1111/jvh.13217. [Epub ahead of print]
|
|
| |
|
|
| |
| 195. | Hepatitis B virus reactivation: Risk factors and current management strategies |
| |
Smalls DJ1, Kiger RE1, Norris LB1,2, Bennett CL1,2,3,4,5, Love BL1,2,3. Pharmacotherapy. 2019 Oct 9. doi: 10.1002/phar.2340. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 201. | Phenotypes of Chronic Hepatitis B in Children from a Large North American Cohort |
| |
Schwarz KB1, Lombardero M2, Di Bisceglie AM3, Murray KF4, Rosenthal P5, Ling SC6, Cloonan YK2, Rodriguez-Baez N7, Schwarzenberg SJ8, Hoofnagle JH9, Teckman J3; Hepatitis B Research Network (HBRN). J Pediatr Gastroenterol Nutr. 2019 Aug 20. doi: 10.1097/MPG.0000000000002467. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 208. | Phenotypes of Chronic Hepatitis B in Children from a Large North American Cohort |
| |
Schwarz KB1, Lombardero M2, Di Bisceglie AM3, Murray KF4, Rosenthal P5, Ling SC6, Cloonan YK2, Rodriguez-Baez N7, Schwarzenberg SJ8, Hoofnagle JH9, Teckman J3; Hepatitis B Research Network (HBRN). J Pediatr Gastroenterol Nutr. 2019 Aug 20. doi: 10.1097/MPG.0000000000002467. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 212. | Modelling progress towards elimination of hepatitis B in Australia |
| |
McCulloch K1,2, Romero N1,3, MacLachlan J1,3, Allard N1,3, Cowie B1,3,4. Hepatology. 2019 Aug 16. doi: 10.1002/hep.30899. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 215. | Predicting HBsAg clearance in genotype A chronic hepatitis B using HBsAg epitope profiling: a biomarker for functional cure |
| |
Walsh R1, Hammond R1, Yuen L1, Deerain J1, O'Donnell T1, Leary T2, Cloherty G2, Gaggar A3, Kitrinos K3, Subramanian M3, Wong D4, Locarnini S1.
Liver Int. 2019 Aug 4. doi: 10.1111/liv.14207. [Epub ahead of print]
|
|
| |
| 216. | Prevalence of Hepatitis B Virus Exposure in the Veterans Health Administration and Association With Military-related Risk Factors |
| |
Beste LA1, Ioannou GN2, Chang MF3, Forsberg CW4, Korpak AM4, Boyko EJ5, Sporleder JL6, Smith NL7, Maynard C8, Chartier M9, Dominitz JA10; VA Cooperative Study Group #488. Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30845-6. doi: 10.1016/j.cgh.2019.07.056. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 219. | Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy |
| |
Fan R1, Zhou B1, Xu M2, Tan D3, Niu J4, Wang H5, Ren H6, Chen X7, Wang M8, Ning Q9, Shi G10, Sheng J11, Tang H12, Bai X13, Liu S1, Lu F14, Peng J1, Sun J15, Xie Q16, Hou J17; Chronic Hepatitis B Study Consortium.Collaborators (9) Clin Gastroenterol Hepatol. 2019 Jul 27. pii: S1542-3565(19)30790-6. doi: 10.1016/j.cgh.2019.07.046. [Epub ahead of print]
|
|
| |
|
|
| |
| 221. | Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement |
| |
US Preventive Services Task Force, Owens DK1,2, Davidson KW3, Krist AH4,5, Barry MJ6, Cabana M7, Caughey AB8, Doubeni CA9, Epling JW Jr10, Kemper AR11, Kubik M12, Landefeld CS13, Mangione CM14, Pbert L15, Silverstein M16, Simon MA17, Tseng CW18,19, Wong JB20. JAMA. 2019 Jul 23;322(4):349-354. doi: 10.1001/jama.2019.9365.
|
|
| |
|
|
| |
| 223. | Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers |
| |
Chang KC1, Chang MH1, Lee CN1, Chang CH1, Wu JF1, Ni YH1, Wen WH2, Shyu MK1, Lai MW3, Chen SM1, Hu JJ1, Lin HH2, Hsu JJ1, Mu SC1, Lin YC2, Liu CJ1, Chen DS1, Lin LH1, Chen HL1; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study). Aliment Pharmacol Ther. 2019 Aug;50(3):306-316. doi: 10.1111/apt.15321. Epub 2019 Jul 4.
|
|
| |
| 224. | Challenges with hepatitis B vaccination of high risk adults - A pilot program |
| |
Bridges CB1, Watson TL2, Nelson NP3, Chavez-Torres M4, Fineis P5, Ntiri-Reid B6, Wake E7, Leahy JM8, Kurian AK9, Hall MAK10, Kennedy ED11. Vaccine. 2019 Jul 11. pii: S0264-410X(19)30746-7. doi: 10.1016/j.vaccine.2019.05.089. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 230. | Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents |
| |
Sasadeusz J1, Grigg A2, Hughes PD3, Lee Lim S4, Lucas M5, McColl G6, McLachlan SA7, Peters MG8, Shackel N9, Slavin M10, Sundararajan V11, Thompson A12, Doyle J13, Rickard J2, De Cruz P14, Gish RG15, Visvanathan K12. Clin Liver Dis. 2019 Aug;23(3):521-534. doi: 10.1016/j.cld.2019.04.012. Epub 2019 Jun 5.
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 238. | Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV coinfected adults |
| |
Sterling RK1, King WC2, Wahed AS2, Kleiner DE3, Khalili M4, Sulkowski M5, Chung RT6, Jain MK7, Lisker-Melman M8, Wong DK9, Ghany MG3; HIV-HBV Cohort Study of the Hepatitis B Research Network. Hepatology. 2019 Jun 20. doi: 10.1002/hep.30825. [Epub ahead of print]
|
|
| |
| 239. | Exploration of long-acting implant formulations of hepatitis B drug entecavir |
| |
Henry SJ1, Barrett SE2, Forster SP1, Teller RS1, Yang Z1, Li L1, Mackey MA1, Doto GJ3, Ruth MP3, Tsuchiya T3, Klein LJ1, Gindy ME1. Eur J Pharm Sci. 2019 Jun 15;136:104958. doi: 10.1016/j.ejps.2019.104958. [Epub ahead of print]
|
|
| |
| 240. | Underreporting of Hepatitis B and C virus infections - Pennsylvania, 2001-2015 |
| |
Roberts H1, Boktor SW2, Waller K2, Daar ZS3, Boscarino JA3, Dubin PH1,4, Suryaprasad A1,5, Moorman AC1. PLoS One. 2019 Jun 6;14(6):e0217455. doi: 10.1371/journal.pone.0217455. eCollection 2019.
|
|
| |
| 241. | Patient-Reported Outcomes in Patients Chronic Viral Hepatitis without Cirrhosis: The Impact of Hepatitis B and C Viral Replication |
| |
Younossi ZM1,2, Stepanova M3, Younossi I3, Papatheodoridis G4, Janssen HLA5, Agarwal K6, Nguyen MH7, Gane E8, Tsai N9, Nader F3. Liver Int. 2019 Jun 7. doi: 10.1111/liv.14171. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 244. | Associations Between Hepatitis B Virus Infection and Risk of All Cancer Types |
| |
Song C1, Lv J2, Liu Y3, Chen JG4, Ge Z1, Zhu J4, Dai J1, Du LB5, Yu C2, Guo Y6, Bian Z6, Yang L6,7, Chen Y6,7, Chen Z6,7, Liu J8, Jiang J9, Zhu L9, Zhai X9, Jiang Y1, Ma H1, Jin G1, Shen H1, Li L2, Hu Z1; China Kadoorie Biobank Collaborative Group. JAMA Netw Open. 2019 Jun 5;2(6):e195718. doi: 10.1001/jamanetworkopen.2019.5718.
|
|
| |
| 245. | Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis Bvirus infection |
| |
Marcellin P1, Wong D2, Sievert W3, Buggisch P4, Petersen J4, Flisiak R5, Manns M6,7, Kaita K8, Krastev Z9, Lee SS10, Cathcart AL11, Crans G11, Op den Brouw M12, Jump B11, Gaggar A11, Flaherty J11, Buti-Ferret M13. Liver Int. 2019 May 28. doi: 10.1111/liv.14155. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 248. | Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients |
| |
Lo Re V 3rd1, Newcomb CW1, Carbonari DM1, Roy JA1, Althoff KN2, Kitahata MM3, Reddy KR1, Lim JK4, Silverberg MJ5, Mayor AM6, Horberg MA7, Cachay ER8, Kirk GD2, Hull M9, Gill J10, Sterling TR11, Kostman JR12, Peters MG13, Moore RD2, Klein MB14, Kim HN3; North American AIDS Cohort Collaboration on Research and Design of IeDEA. J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002094. [Epub ahead of print]
|
|
| |
|
|
| |
| 250. | Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells |
| |
Dias J1, Hengst J2, Parrot T1, Leeansyah E3, Lunemann S4, Malone DFG1, Hardtke S5, Strauss O1, Zimmer CL1, Berglin L1, Schirdewahn T5, Ciesek S6, Marquardt N1, von Hahn T5, Manns MP5, Cornberg M5, Ljunggren HG1, Wedemeyer H7, Sandberg JK1, Björkström NK8. J Hepatol. 2019 May 6. pii: S0168-8278(19)30270-3. doi: 10.1016/j.jhep.2019.04.009. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 256. | A global scientific strategy to cure hepatitis B |
| |
Revill PA1, Chisari FV2, Block JM3, Dandri M4, Gehring AJ5, Guo H6, Hu J7, Kramvis A8, Lampertico P9, Janssen HLA10, Levrero M11, Li W12, Liang TJ13, Lim SG14, Lu F15, Penicaud MC16, Tavis JE17, Thimme R18; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors, Zoulim F19. Lancet Gastroenterol Hepatol. 2019 Apr 10. pii: S2468-1253(19)30119-0. doi: 10.1016/S2468-1253(19)30119-0. [Epub ahead of print]
|
|
| |
|
|
| |
| 258. | Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infection |
| |
Post G1,2, Shalev N3, Baumgarten A2, Shimakawa Y4, Lemoine M5, Krznaric I2, Dupke S2, Carganico A2, Arastéh K6, Ingiliz P2. Eur J Gastroenterol Hepatol. 2019 Apr 5. doi: 10.1097/MEG.0000000000001409. [Epub ahead of print]
|
|
| |
|
|
| |
| 260. | Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus |
| |
Salvadori N1,2, Fan B3, Teeyasoontranon W4, Ngo-Giang-Huong N1,2,5, Phanomcheong S6, Luvira A7, Puangsombat A8, Suwannarat A9, Srirompotong U10, Putiyanun C11, Cressey TR1,2,5,12, Decker L1,2, Khamduang W2, Harrison L13, Tierney C13, Shepherd JA3,14, Kourtis AP15, Bulterys M15,16, Siberry GK17, Jourdain G1,2,5. Clin Infect Dis. 2019 Mar 29. pii: ciy982. doi: 10.1093/cid/ciy982. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 263. | Age, race and viral genotype are associated with the prevalence of Hepatitis B e antigen in children and adults with chronic Hepatitis B |
| |
Di Bisceglie AM1, King WC2, Lisker-Melman M3, Khalili M4, Belle SH2, Feld JJ5, Ghany MG6, Janssen HLA5, Lau D7, Lee WM8, Ling SC5, Cooper S9, Rosenthal P4, Schwarz KB10, Sterling RK11, Teckman JH1, Terrault N4; Hepatitis B Research Network (HBRN). J Viral Hepat. 2019 Apr 11. doi: 10.1111/jvh.13104. [Epub ahead of print]
Collaborators (37)
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 268. | Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B |
| |
Lee TY1,2, Hsu YC3,4,5,6, Tseng HC7, Yu SH1, Lin JT4,8, Wu MS9, Wu CY7,10,11,12. JAMA Intern Med. 2019 Mar 18. doi: 10.1001/jamainternmed.2018.8342. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 273. | Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation |
| |
Ikeda A1, Takaki A, Yasunaka T, Oyama A, Adachi T, Wada N, Onishi H, Ikeda F, Shiraha H, Yoshida K, Kuise T, Nobuoka D, Yoshida R, Umeda Y, Yagi T, Fujiwara T, Okada H. Acta Med Okayama. 2019 Feb;73(1):41-50. doi: 10.18926/AMO/56457.
|
|
| |
|
|
| |
| 275. | Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials |
| |
Buti M1, Wong DK2, Gane E3, Flisiak R4, Manns M5, Kaita K6, Janssen HLA2, Op den Brouw M7, Jump B8, Kitrinos K8, Crans G8, Flaherty J8, Gaggar A8, Marcellin P9. Lancet Gastroenterol Hepatol. 2019 Apr;4(4):296-304. doi: 10.1016/S2468-1253(19)30015-9. Epub 2019 Feb 20.
|
|
| |
| 276. | The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals |
| |
Popping S1, Bade D2, Boucher C1,2, van der Valk M3, El-Sayed M4, Sigurour O5, Sypsa V6, Morgan T7, Gamkrelidze A8, Mukabatsinda C9, Deuffic-Burban S10, Ninburg M11, Feld J12, Hellard M13, Ward J14,15. J Virus Erad. 2019 Jan 1;5(1):60-66.
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 281. | A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs - do gender differences vary by country-level indicators? |
| |
Leung J1, Peacock A1, Colledge S2, Grebely J3, Cunningham EB3, Hickman M4, Vickerman P4, Stone J4, Trickey A4, Dumchev K5, Lynskey M6, Hines L4, Griffiths P7, Mattick RP1, Degenhardt L1, Larney S1. J Infect Dis. 2019 Feb 6. doi: 10.1093/infdis/jiz058. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 285. | Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses - United States, 2010-2017 |
| |
Abara WE, Collier MG, Moorman A, Bixler D, Jones J, Annambhotla P, Bowman J, Levi ME, Brooks JT, Basavaraju SV. MMWR Morb Mortal Wkly Rep. 2019 Jan 25;68(3):61-66. doi: 10.15585/mmwr.mm6803a2. |
|
| |
| 286. | Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices |
| |
Ramsey SD1, Unger JM2,3, Baker LH4, Little RF5, Loomba R6, Hwang JP7, Chugh R4, Konerman MA4, Arnold K2,3, Menter AR8, Thomas E9, Michels RM10, Jorgensen CW10, Burton GV11, Bhadkamkar NA7, Hershman DL12. JAMA Oncol. 2019 Jan 17. doi: 10.1001/jamaoncol.2018.6437. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 289. | Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir |
| |
Kong Y1, Sun Y1, Zhou J1, Wu X1, Chen Y2, Piao H3, Lu L4, Ding H5, Nan Y6, Jiang W7, Xu Y8, Xie W9, Li H10, Feng B11, Shi G12, Chen G13, Li H14, Zheng H15, Cheng J16, Wang T17, Liu H18, Fudong L18, Chen S17, Mao Y19, Sun J20, Chen T21, Han T22, Han Y23, Wang L1, Ou X1, Zhang H24, Jia J1, You H1. J Viral Hepat. 2019 Jan 9. doi: 10.1111/jvh.13058. [Epub ahead of print] |
|
| |
|
|
| |
| 291. | Discovery of half-life of circulating HBsAg in patients with chronic hepatitis B infection using heavy water labeling |
| |
Loomba R1, Decaris M2, Li KW2,3, Shankaran M3, Mohammed H2,3, Matthews M2,3, Richards LM1, Nguyen P1, Rizo E1, Andrews B1, Soto R1, Angel T3, Suri V4, Kitrinos KM4, Barnes D4, Czerwieniec G4, Brendza K4, Subramanian GM4, Gaggar A4, Hellerstein MK2,3. Clin Infect Dis. 2018 Dec 24. doi: 10.1093/cid/ciy1100. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 294. | Defining the therapeutic range for adalimumab and predicting response in psoriasis: a multicenter prospective observational cohort study |
| |
Wilkinson N1, Tsakok T2, Dand N2, Bloem K3, Duckworth M4, Baudry D4, Pushpa-Rajah A4, Griffiths CE5, Reynolds N6, Barker J2, Warren RB5, Burden AD7, Rispens T3, Stocken D8, Smith C9; BSTOP study group and PSORT consortium. J Invest Dermatol. 2018 Aug 18. pii: S0022-202X(18)32482-5. doi: 10.1016/j.jid.2018.07.028. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 300. | Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues |
| |
Chevaliez S1,2, Rodriguez C1,2, Poiteau L1,2, Soulier A1,2, Donati F1,2, Darty-Mercier M1,2, Pioche C3, Leroy V4,5, Brodard V6, Zoulim F7,8, Brouard C3, Larsen C3, Semaille C3, Roudot-Thoraval F9, Pawlotsky JM1,2; Hepatology Reference Centers Laboratories Network for Chronic Hepatitis BSurveillance. J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13025. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 313. | B in IT - a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical tool |
| |
O'Leary DA1, Cropp E1, Isaac D2,3, Desmond PV1, Bell S1, Nguyen T1, Wong D1, Howell J1, Richmond J4,5,6, O'Neill J7, Thompson AJ1. Hepatol Med Policy. 2018 Jan 4;3:1. doi: 10.1186/s41124-017-0031-2. eCollection 2018. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 319. | Hepatitis B and C |
| |
Mysore KR1, Leung DH2. Clin Liver Dis. 2018 Nov;22(4):703-722. doi: 10.1016/j.cld.2018.06.002. Epub 2018 Aug 22. |
|
| |
|
|
| |
|
|
| |
| 322. | Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study |
| |
Groom HC1, Irving SA2, Koppolu P2, Smith N2, Vazquez-Benitez G3, Kharbanda EO3, Daley MF4, Donahue JG5, Getahun D6, Jackson LA7, Tse Kawai A8, Klein NP9, McCarthy NL10, Nordin JD3, Sukumaran L10, Naleway AL2. Vaccine. 2018 Oct 1;36(41):6111-6116. doi: 10.1016/j.vaccine.2018.08.074. Epub 2018 Sep 5. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 331. | Mortality among Patients with Chronic Hepatitis B (CHB) Infection: the Chronic Hepatitis Cohort Study (CHeCS) |
| |
Bixler D1, Zhong Y1, Ly KN1, Moorman AC1, Spradling PR1, Teshale EH1, Rupp L LB2, Gordon SC2, Boscarino JA3, Schmidt MA4, Daida YG5, Holmberg SD1; CHeCS Investigators. Clin Infect Dis. 2018 Jul 28. doi: 10.1093/cid/ciy598. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 338. | Association Between Hepatitis B Infection and Pancreatic Cancer: A Population-Based Analysis in the United States |
| |
Desai R, Patel U1, Sharma S2, Singh S3, Doshi S4, Shaheen S5, Shamim S6, Korlapati LS7, Balan S8, Bray C4, Williams R9, Shah N10. Pancreas. 2018 Aug;47(7):849-855. doi: 10.1097/MPA.0000000000001095. |
|
| |
|
|
| |
| 340. | Safety and Efficacy of Vesatolimod (GS-9620) in Patients with Chronic Hepatitis B Who Are Not Currently on Antiviral Treatment |
| |
Agarwal K1, Ahn SH2, Elkhashab M3, Lau AH4, Gaggar A4, Bulusu A4, Tian X4, Cathcart AL4, Woo J4, Subramanian GM4, Andreone P5, Kim HJ6, Chuang WL7, Nguyen MH8. J Viral Hepat. 2018 May 31. doi: 10.1111/jvh.12942. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 345. | Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study |
| |
Stasi C1, Silvestri C1, Berni R2, Brunetto MR3, Zignego AL4, Orsini C2, Milani S5, Ricciardi L6, De Luca A7, Blanc P8, Nencioni C9, Aquilini D10, Bartoloni A11, Bresci G12, Marchi S13, Filipponi F14, Colombatto P3, Forte P5, Galli A5, Luchi S6, Chigiotti S9, Nerli A10, Corti G11, Sacco R12, Carrai P14, Ricchiuti A13, Giusti M15, Almi P16, Cozzi A5, Carloppi S17, Laffi G18, Voller F1, Cipriani F19. World J Hepatol. 2018 May 27;10(5):409-416. doi: 10.4254/wjh.v10.i5.409. |
|
| |
|
|
| |
| 347. | Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial |
| |
Yim HJ1, Kim IH2, Suh SJ1, Jung YK1,3, Kim JH4, Seo YS5, Yeon JE4, Kim CW6, Kwon SY7, Park SH8, Lee MS8, Um SH5, Byun KS4. J Viral Hepat. 2018 May 17. doi: 10.1111/jvh.12934. [Epub ahead of print] |
|
| |
|
|
| |
| 349. | Hepatitis D Viremia Among Injection Drug Users in San Francisco |
| |
Mahale P1, Aka PV1,2, Chen X3,4, Liu P3, Fram BJ5, Wang AS1, Simenel S5, Tseng FC1, Chen S6, Edlin BR7,8, Glenn JS3,5, O'Brien TR1. J Infect Dis. 2018 May 25;217(12):1902-1906. doi: 10.1093/infdis/jiy157. |
|
| |
|
|
| |
|
|
| |
| 352. | Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal |
| |
Manini MA1, Whitehouse G2, Bruce M2, Passerini M3, Lim TY2, Carey I2, Considine A2, Lampertico P3, Suddle A2, Heaton N2, Heneghan M2, Agarwal K2. Dig Liver Dis. 2018 Apr 13. pii: S1590-8658(18)30673-X. doi: 10.1016/j.dld.2018.03.032. [Epub ahead of print] |
|
| |
| 353. | Community-Based Services to Improve Testing and Linkage to Care Among Non-U.S.-Born Persons with Chronic Hepatitis B Virus Infection - Three U.S. Programs, October 2014-September 2017 |
| |
Harris AM, Link-Gelles R, Kim K, Chandrasekar E, Wang S, Bannister N, Pong P, Chak E, Chen MS Jr, Bowlus C, Nelson NP. MMWR Morb Mortal Wkly Rep. 2018 May 18;67(19):541-546. doi: 10.15585/mmwr.mm6719a2. |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 357. | Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children with Chronic Hepatitis B: The PEG-B-ACTIVE Study |
| |
Wirth S1, Zhang H2, Hardikar W3, Schwarz KB4, Sokal E5, Yang W6, Fan H7, Morozov V8, Mao Q9, Deng H10, Yang Huang11, Yang L11, Frey N12, Nasmyth-Miller C13, Pavlovic V13, Wat C13. Hepatology. 2018 Apr 24. doi: 10.1002/hep.30050. [Epub ahead of print] |
|
| |
| 358. | When do co-infections matter? |
| |
McArdle AJ1, Turkova A2, Cunnington AJ3. Curr Opin Infect Dis. 2018 Jun;31(3):209-215. doi: 10.1097/QCO.0000000000000447. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 367. | Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B |
| |
Khalili M1, Shuhart MC2, Lombardero M3, Feld JJ4, Kleiner DE5, Chung RT6, Terrault NA7, Lisker-Melman M8, Sanyal A9, Lok AS10; Hepatitis B Research Network (HBRN). Collaborators (36) Diabetes Care. 2018 Mar 29. pii: dc180040. doi: 10.2337/dc18-0040. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 372. | When do coinfections matter? |
| |
McArdle AJ1, Turkova A2, Cunnington AJ3. Curr Opin Infect Dis. 2018 Mar 22. doi: 10.1097/QCO.0000000000000447. [Epub ahead of print] |
|
| |
|
|
| |
| 374. | Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B |
| |
Jourdain G1, Ngo-Giang-Huong N1, Harrison L1, Decker L1, Khamduang W1, Tierney C1, Salvadori N1, Cressey TR1, Sirirungsi W1, Achalapong J1, Yuthavisuthi P1, Kanjanavikai P1, Na Ayudhaya OP1, Siriwachirachai T1, Prommas S1, Sabsanong P1, Limtrakul A1, Varadisai S1, Putiyanun C1, Suriyachai P1, Liampongsabuddhi P1, Sangsawang S1, Matanasarawut W1, Buranabanjasatean S1, Puernngooluerm P1, Bowonwatanuwong C1, Puthanakit T1, Klinbuayaem V1, Thongsawat S1, Thanprasertsuk S1, Siberry GK1, Watts DH1, Chakhtoura N1, Murphy TV1, Nelson NP1, Chung RT1, Pol S1, Chotivanich N1. N Engl J Med. 2018 Mar 8;378(10):911-923. doi: 10.1056/NEJMoa1708131. |
|
| |
| 375. | Effect of Hepatitis B virus on Steatosis in Hepatitis C virus co-infected subjects: a multi-center study and systematic review |
| |
Goossens N1, de Vito C2, Mangia A3, Clément S2, Cenderello G4, Barrera F5, D'Ambrosio R6, Coppola N7, Zampino R8, Stanzione M9, Adinolfi LE8, Wedemeyer H10, Semmo N11, Müllhaupt B12, Semela D13, Malinverni R14, Moradpour D15, Heim M16, Trincucci G17, Rubbia-Brandt L2, Negro F1,2; BOSTIC Study Group. J Viral Hepat. 2018 Mar 13. doi: 10.1111/jvh.12891. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 384. | Improving a process to obtain hepatitis B serology among patients treated with infliximab at a large urban children's hospital |
| |
Jean MR1, Weaver A1, Mastin-Diebold T1, Kissinger K1, Smitherman EA2, Favier L2, Danziger-Isakov L3, Williams E1, Brady RC3, Huggins J2, Denson LA1, Saeed SA1, Morgan P1, Dykes DMH1. BMJ Open Qual. 2017 Oct 18;6(2):e000092. doi: 10.1136/bmjoq-2017-000092. eCollection 2017. |
|
| |
|
|
| |
| 386. | 8-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population |
| |
Papatheodoridis GV1, Sypsa V2, Dalekos G3, Yurdaydin C4, Van Boemmel F5, Buti M6, Goulis J7, Luis Calleja J8, Chi H9, Manolakopoulos S10, Loglio A11, Siakavellas S12, Gatselis N3, Kesk?n O4, Lehretz M5, Savvidou S7, de la Revilla J8, Hansen BE9, Kourikou A10, Vlachogiannakos I12, Galanis K3, Idilman R4, Colombo M13, Esteban R6, Janssen HLA14, Berg T5, Lampertico P11. J Hepatol. 2018 Feb 7. pii: S0168-8278(18)30081-3. doi: 10.1016/j.jhep.2018.01.031. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 390. | Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis |
| |
Rinaldi L1, Ascione A2, Messina V3, Rosato V4, Valente G5, Sangiovanni V6, Zampino R4, Marrone A4, Fontanella L4, de Rosa N7, Orabona P8, Buonomo C8, Chirianni A6, Adinolfi LE4, Piai G5. Infection. 2018 Jan 15. doi: 10.1007/s15010-017-1113-1. [Epub ahead of print] |
|
| |
|
|
| |
| 392. | Factors associated with non-adherence to HBV antiviral therapy |
| |
Sheppard-Law S1,2,3, Zablotska-Manos I3, Kermeen M4, Holdaway S5, Lee A4, George J5,6, Zekry A7,8, Maher L3. Antivir Ther. 2017 Jan 22. doi: 10.3851/IMP3219. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 397. | Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis Bvaccine in adults |
| |
Jackson S1, Lentino J2, Kopp J3, Murray L4, Ellison W5, Rhee M6, Shockey G7, Akella L8, Erby K9, Heyward WL10, Janssen RS11; HBV-23 Study Group. Vaccine. 2017 Dec 27. pii: S0264-410X(17)31791-7. doi: 10.1016/j.vaccine.2017.12.038. [Epub ahead of print] |
|
| |
| 398. | Impact of Enhanced Health Interventions for United States-Bound Refugees: Evaluating Best Practices in Migration Health |
| |
Mitchell T1, Lee D1, Weinberg M1, Phares C1, James N2, Amornpaisarnloet K2, Aumpipat L2, Cooley G3, Davies A2, Tin Shwe VD2, Gajdadziev V2, Gorbacheva O2, Khwan-Niam C2, Klosovsky A4, Madilokkowit W2, Martin D3, Htun Myint NZ2, Yen Nguyen TN2, Nutman TB5, O'Connell EM5, Ortega L1, Prayadsab S2, Srimanee C2, Supakunatom W2, Vesessmith V2, Stauffer WM6,1. Am J Trop Med Hyg. 2017 Dec 18. doi: 10.4269/ajtmh.17-0725. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 402. | Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop |
| |
Block TM1, Alter H2, Brown N3, Brownstein A4, Brosgart C5, Chang KM6, Chen PJ7, Cohen C3, El-Serag H8, Feld J9, Gish R10, Glenn J11, Greten TF12, Guo JT4, Hoshida Y13, Kowdley KV14, Li W15, Lok AS16, McMahon B17, Mehta A18, Perrillo R19, Rice CM20, Rinaudo J12, Schinazi RF21, Shetty K22.Author informationAntiviral Res. 2017 Dec 14;150:93-100. doi: 10.1016/j.antiviral.2017.12.006. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 409. | The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing |
| |
Tucker JD1,2,3, Meyers K4,5, Best J4,6,7, Kaplan K7, Pendse R8, Fenton KA4,9, Andrieux-Meyer I10, Figueroa C11, Goicochea P12, Gore C13,14, Ishizaki A14, Khwairakpam G15, Miller V12, Mozalevskis A16, Ninburg M17, Ocama P18, Peeling R19, Walsh N20, Colombo MG21,22, Easterbrook P11. BMC Infect Dis. 2017 Nov 1;17(Suppl 1):701. doi: 10.1186/s12879-017-2771-4. |
|
| |
| 410. | Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis |
| |
Amini A1, Varsaneux O1, Kelly H1, Tang W2,3, Chen W4, Boeras DI1, Falconer J1, Tucker JD2,3, Chou R5, Ishizaki A6, Easterbrook P6, Peeling RW7. BMC Infect Dis. 2017 Nov 1;17(Suppl 1):698. doi: 10.1186/s12879-017-2772-3. |
|
| |
| 411. | Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses |
| |
Lange B1,2, Cohn J3, Roberts T4, Camp J5, Chauffour J6, Gummadi N7, Ishizaki A8, Nagarathnam A9, Tuaillon E10,11, van de Perre P10,11, Pichler C12, Easterbrook P8, Denkinger CM4. BMC Infect Dis. 2017 Nov 1;17(Suppl 1):700. doi: 10.1186/s12879-017-2777-y. |
|
| |
| 412. | Vaccinations in Older Adults |
| |
Burke M1, Rowe T2. Clin Geriatr Med. 2018 Feb;34(1):131-143. doi: 10.1016/j.cger.2017.08.006. Epub 2017 Oct 14. |
|
| |
|
|
| |
| 414. | Safety, Efficacy and Pharmacodynamics of Vesatolimod (GS-9620) in Virally-Suppressed Patients with Chronic Hepatitis B |
| |
Janssen HLA1, Brunetto MR2, Kim YJ3, Ferrari C4, Massetto B5, Nguyen AH5, Joshi A5, Woo J5, Lau AH5, Gaggar A5, Subramanian GM5, Yoshida EM6, Ahn SH7, Tsai NCS8, Fung S9, Gane EJ10. J Hepatol. 2017 Nov 2. pii: S0168-8278(17)32408-X. doi: 10.1016/j.jhep.2017.10.027. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 419. | The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015 |
| |
Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T1, Abera S2,3, Ahmed M4, Alam N5,6, Alemayohu MA7, Allen C8, Al-Raddadi R9, Alvis-Guzman N10, Amoako Y11, Artaman A12, Ayele TA13, Barac A14, Bensenor I15, Berhane A16, Bhutta Z17,18, Castillo-Rivas J19, Chitheer A20, Choi JY21, Cowie B22, Dandona L8,23, Dandona R8,23, Dey S24, Dicker D8, Phuc H25, Ekwueme DU26, Zaki MES27, Fischer F28, Fürst T29,30,31, Hancock J8, Hay SI8, Hotez P32,33, Jee SH34, Kasaeian A35, Khader Y36, Khang YH37, Kumar GA38, Kutz M8, Larson H39, Lopez A8,40, Lunevicius R41,42, Malekzadeh R43, McAlinden C44, Meier T45, Mendoza W46, Mokdad A8, Moradi-Lakeh M47,48, Nagel G49, Nguyen Q25, Nguyen G8, Ogbo F50,51, Patton G52, Pereira DM53, Pourmalek F54, Qorbani M55, Radfar A56, Roshandel G57, Salomon JA58, Sanabria J59,60, Sartorius B61, Satpathy M62,63, Sawhney M64, Sepanlou S43, Shackelford K8, Shore H65, Sun J66, Mengistu DT67, Topór-Madry R68,69, Tran B70,71, Ukwaja KN72, Vlassov V73, Vollset SE74,75, Vos T8, Wakayo T76, Weiderpass E77,78,79, Werdecker A80, Yonemoto N81, Younis M82,83, Yu C84, Zaidi Z85,86, Zhu L87, Murray CJL8, Naghavi M8, Fitzmaurice C8,88. JAMA Oncol. 2017 Oct 5. doi: 10.1001/jamaoncol.2017.3055. [Epub ahead of print] |
|
| |
| 420. | Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B |
| |
Seto WK1, Hui RW2, Mak LY2, Fung J3, Cheung KS2, Liu KS2, Wong DK3, Lai CL3, Yuen MF4. Clin Gastroenterol Hepatol. 2017 Sep 29. pii: S1542-3565(17)31186-2. doi: 10.1016/j.cgh.2017.09.044. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 423. | Incidence, determinants and outcomes of pregnancy-associated hepatitis Bflares: A regional hospital-based cohort study |
| |
Kushner T1,2,3, Shaw PA3, Kalra A4, Magaldi L5, Monpara P5, Bedi G6, Krok K6, Centkowski S2, Dalldorf K2, D'souza J2, Halegoua-De Marzio D4, Goldberg DS2,3, Trooskin S5, Levine LD7, Srinivas SK7, Lewis JD2,3, Forde KA2,3, Lo Re V 3rd3,8. Liver Int. 2017 Sep 20. doi: 10.1111/liv.13594. [Epub ahead of print] |
|
| |
| 424. | Hepatitis B, hepatitis C and mortality among HIV-positive individuals |
| |
Thornton AC, Jose S, Bhagani S, Chadwick D, Dunn D, Gilson R, Main J, Nelson M, Rodger A, Taylor C, Youssef E, Leen C, Gompels M, Kegg S, Schwenk A, Sabin C; UK Collaborative HIV cohort (UK CHIC) steering committee. AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001646. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 430. | Pregnancy outcome in more than 5000 births to women with viral hepatitis: a population-based cohort study in Sweden |
| |
Stokkeland K1,2, Ludvigsson JF3,4,5, Hultcrantz R6,7, Ekbom A8, Höijer J9, Bottai M9, Stephansson O8,10. Eur J Epidemiol. 2017 May 26. doi: 10.1007/s10654-017-0261-z. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 434. | Infrequent clinical assessment of chronic hepatitis B patients in United States general healthcare settings |
| |
Spradling PR1, Xing J1, Rupp LB1, Moorman AC1, Gordon SC1, Teshale ET1, Lu M1, Boscarino JA1, Trinacty CM1, Schmidt MA1, Holmberg SD1; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Clin Infect Dis. 2016 Aug 2. pii: ciw516. [Epub ahead of print] |
|
| |
| 435. | Factors associated with poor adherence to antiviral treatment for hepatitis B |
| |
Allard N1,2, Dev A2,3,4, Dwyer J5, Srivatsa G6, Thompson A2,7, Cowie B1,2. J Viral Hepat. 2016 Aug 9. doi: 10.1111/jvh.12582. [Epub ahead of print] |
|
| |
| 436. | Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load |
| |
Pan CQ1, Duan Z1, Dai E1, Zhang S1, Han G1, Wang Y1, Zhang H1, Zou H1, Zhu B1, Zhao W1, Jiang H1; China Study Group for the Mother-to-Child Transmission of Hepatitis B. N Engl J Med. 2016 Jun 16;374(24):2324-34. doi: 10.1056/NEJMoa1508660. |
|
| |
|
|
| |
| 438. | Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study |
| |
Ahn J1, Lim JK2, Lee HM3, Lok AS4, Nguyen M5, Pan CQ6, Mannalithara A5, Te H7, Reddy KR8, Trinh H9, Chu D10, Tran T11, Lau D12, Leduc TS13, Min A14, Trong Le L15, Bae H16, Van Tran S17, Do S18, Hann HL19, Wong C20, Han S21, Pillai A22, Park JS23, Tong M22, Scaglione S24, Woog J25, Kim WR5. Am J Gastroenterol. 2016 Jun 21. doi: 10.1038/ajg.2016.257. [Epub ahead of print] |
|
| |
|
|
| |
| 440. | International collaborative study on the 3rd WHO International Standard for hepatitis B surface antigen |
| |
Wilkinson DE1, Seiz PL2, Schüttler CG2, Gerlich WH2, Glebe D2, Scheiblauer H3, Nick S3, Chudy M3, Dougall T4, Stone L5, Heath AB4; Collaborative Study Group. J Clin Virol. 2016 Jun 6. pii: S1386-6532(16)30135-4. doi: 10.1016/j.jcv.2016.06.003. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 444. | Are current screening protocols for chronic hepatitis B virus infection adequate? |
| |
Mortensen E1, Kamali A1, Schirmer PL2, Lucero-Obusan C2, Winston CA3, Oda G2, Winters MA1, Durfee J2, Martinello RA4, Davey VJ2, Holodniy M5. Diagn Microbiol Infect Dis. 2015 Dec 17. pii: S0732-8893(15)00442-3. doi: 10.1016/j.diagmicrobio.2015.12.005. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 448. | Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014 |
| |
Williams WW1, Lu PJ, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, Rodriguez-Lainz A, Bridges CB. MMWR Surveill Summ. 2016 Feb 5;65(1):1-36. doi: 10.15585/mmwr.ss6501a1. |
|
| |
| 449. | Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France |
| |
Marcellin P1, Zoulim F2, Hézode C3, Causse X4, Roche B5, Truchi R6, Pauwels A7, Ouzan D8, Dumortier J9, Pageaux GP10, Bourlière M11, Riachi G12, Zarski JP13, Cadranel JF14, Tilliet V15, Stern C15, Pétour P16, Libert O15, Consoli SM17, Larrey D18. Dig Dis Sci. 2016 Jan 28. [Epub ahead of print] |
|
| |
| 450. | Insomnia in Adults With Chronic Hepatitis B, Liver Failure, and Cirrhosis: A Case- |
| |
Guo HM1, Liu M1, Xiang YT2, Zhao J1, Ungvari GS3, Correll CU4, Ng CH5, Chiu HF6, Duan ZP1. Perspect Psychiatr Care. 2015 Dec 3. doi: 10.1111/ppc.12138. [Epub ahead of print] |
|
| |
| 451. | Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis |
| |
Jonas MM1, Lok AS2, McMahon BJ3, Brown RS Jr4, Wong JB5, Ahmed AT6,7, Farah W6,7, Mouchli MA8, Singh S9, Prokop LJ10, Murad MH6,7,11, Mohammed K6,7,11. Hepatology. 2015 Nov 13. doi: 10.1002/hep.28278. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 455. | Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study |
| |
Ahn J1, Lee HM2, Lim JK3, Pan CQ4, Nguyen MH5, Ray Kim W5, Mannalithara A5, Trinh H6, Chu D7, Tran T8, Min A9, Do S10, Te H11, Reddy KR12, Lok AS13. Aliment Pharmacol Ther. 2015 Oct 28. doi: 10.1111/apt.13440. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 459. | Combination of Tenofovir Disoproxil Fumarate and Peginterferon alfa-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B |
| |
Marcellin P1, Ahn SH2, Ma X3, Caruntu FA4, Tak WY5, Elkashab M6, Chuang WL7, Lim SG8, Tabak F9, Mehta R10, Petersen J11, Foster GR12, Lou L13, Martins EB14, Dinh P14, Lin L14, Corsa A14, Charuworn P14, Subramanian GM14, Reiser H14, Reesink HW15, Fung S16, Strasser SI17, Trinh H18, Buti M19, Gaeta GB20, Hui AJ21, Papatheodoridis G22, Flisiak R23, Chan HL24; study 149 investigators. Gastroenterology. 2015 Oct 7. pii: S0016-5085(15)01429-8. doi: 10.1053/j.gastro.2015.09.043. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 472. | Randomized Controlled Trial of Entecavir Versus Placebo in Children with HBeAg-positive Chronic Hepatitis B |
| |
Jonas MM1, Chang MH2, Sokal E3, Schwarz KB4, Kelly D5, Mo Kim K6, Ling SC7, Rosenthal P8, Oraseanu D9, Reynolds L10, Thiry A10, Ackerman P10. Hepatology. 2015 Jul 29. doi: 10.1002/hep.28015. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 475. | Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients |
| |
Watanabe T1, Tokumoto Y, Joko K, Michitaka K, Mashiba T, Hiraoka A, Ochi H, Koizumi Y, Tada F, Hirooka M, Yoshida O, Imai Y, Abe M, Hiasa Y. Hepatol Int. 2015 Jul 22. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 478. | The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma |
| |
Wang Q1, Blank S, Fiel MI, Kadri H, Luan W, Warren L, Zhu A, Deaderick PA, Sarpel U, Labow DM, Hiotis SP. Ann Surg Oncol. 2015 Jul 10. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 481. | Outcomes of Infants Born to Women Infected With Hepatitis B |
| |
Schillie S1, Walker T2, Veselsky S3, Crowley S4, Dusek C5, Lazaroff J6, Morris SA7, Onye K8, Ko S3, Fenlon N9, Nelson NP3, Murphy TV3. Pediatrics. 2015 Apr 20. pii: peds.2014-3213. [Epub ahead of print] |
|
| |
| 482. | The Epidemiology of Acute Hepatitis B in the United States from Population-Based Surveillance, 2006-2011 |
| |
Iqbal K1, Klevens RM1, Kainer MA2, Baumgartner J3, Gerard K4, Poissant T5, Sweet K6, Vonderwahl C7, Knickerbocker T8, Khudyakov Y1, Xia GL1, Roberts H1, Teshale E1. Clin Infect Dis. 2015 Apr 22. pii: civ332. [Epub ahead of print] |
|
| |
|
|
| |
| 484. | Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles |
| |
Bastani R1, Glenn BA2, Maxwell AE2, Jo AM3, Herrmann AK2, Crespi CM2, Wong WK2, Chang LC2, Stewart SL4, Nguyen TT5, Chen MS Jr6, Taylor VM7. Cancer Epidemiol Biomarkers Prev. 2015 Jun 23. pii: cebp.1396.2014. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 489. | Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment |
| |
Shin SK1, Kim JH2, Park H1, Kwon OS1, Lee HJ3, Yeon JE3, Byun KS3, Suh SJ4, Yim HJ4, Kim YS1, Kim JH1. J Gastroenterol Hepatol. 2015 Jun 11. doi: 10.1111/jgh.13020. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 494. | Long-term safety of oral nucleos(t)ide analogues for patients with chronic hepatitis B - a cohort study of 53,500 subjects |
| |
Wong GL1,2,3, Tse YK1,2, Wong VW1,2,3, Fung TY4, Choi KK5, Chan HL1,2,3. Hepatology. 2015 May 14. doi: 10.1002/hep.27894. [Epub ahead of print] |
|
| |
|
|
| |
| 496. | Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir |
| |
Kim BG1, Jung SW1, Kim EH1, Kim JH1, Park JH1, Sung SJ1, Park BR2, Kim MH2, Kim CJ2, Lee BU1, Park JH1, Jeong ID1, Bang SJ1, Shin JW1, Park NH1,2. J Gastroenterol Hepatol. 2015 May 14. doi: 10.1111/jgh.12993. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 501. | Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load |
| |
Sinn DH1, Lee J1, Goo J2, Kim K2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1. Hepatology. 2015 May 11. doi: 10.1002/hep.27889. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 506. | Outcomes of Infants Born to Women Infected With Hepatitis B |
| |
Schillie S1, Walker T2, Veselsky S3, Crowley S4, Dusek C5, Lazaroff J6, Morris SA7, Onye K8, Ko S3, Fenlon N9, Nelson NP3, Murphy TV3. Pediatrics. 2015 Apr 20. pii: peds.2014-3213. [Epub ahead of print] |
|
| |
| 507. | The Epidemiology of Acute Hepatitis B in the United States from Population-Based Surveillance, 2006-2011 |
| |
Iqbal K1, Klevens RM1, Kainer MA2, Baumgartner J3, Gerard K4, Poissant T5, Sweet K6, Vonderwahl C7, Knickerbocker T8, Khudyakov Y1, Xia GL1, Roberts H1, Teshale E1. Clin Infect Dis. 2015 Apr 22. pii: civ332. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 527. | Cancer risk in HBV patients with statin and metformin use: a population-based cohort study |
| |
Chen CI1, Kuan CF, Fang YA, Liu SH, Liu JC, Wu LL, Chang CJ, Yang HC, Hwang J, Miser JS, Wu SY. Medicine (Baltimore). 2015 Feb;94(6):e462. doi: 10.1097/MD.0000000000000462. |
|
| |
|
|
| |
|
|
| |
| 530. | Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection |
| |
Song LW1, Liu PG2, Liu CJ3, Zhang TY1, Cheng XD4, Wu HL3, Yang HC3, Hao XK4, Yuan Q5, Zhang J6, Kao JH3, Chen DS3, Chen PJ7, Xia NS8. Clin Microbiol Infect. 2014 Oct 29. pii: S1198-743X(14)00063-9. doi: 10.1016/j.cmi.2014.10.002. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 533. | Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure |
| |
Zeisel MB1, Lucifora J2, Mason WS3, Sureau C4, Beck J5, Levrero M6, Kann M7, Knolle PA8, Benkirane M9, Durantel D2, Michel ML10, Autran B11, Cosset FL12, Strick-Marchand H13, Trépo C14, Kao JH15, Carrat F16, Lacombe K16, Schinazi RF17, Barré-Sinoussi F18, Delfraissy JF19, Zoulim F14. Gut. 2015 Feb 10. pii: gutjnl-2014-308943. doi: 10.1136/gutjnl-2014-308943. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 536. | Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European liver transplant registry |
| |
Adam R1, Delvart V, Karam V, Ducerf C, Navarro F, Letoublon C, Belghiti J, Pezet D, Castaing D, Le Treut YP, Gugenheim J, Bachellier P, Pirenne J, Muiesan P; all the ELTR contributing centres, the European Liver, Intestine Transplant Association (ELITA). Am J Transplant. 2015 Feb;15(2):395-406. doi: 10.1111/ajt.13060. |
|
| |
| 537. | Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues |
| |
Fan R1, Sun J1, Yuan Q2, Xie Q3, Bai X4, Ning Q5, Cheng J6, Yu Y7, Niu J8, Shi G9, Wang H10, Tan D11, Wan M12, Chen S13, Xu M14, Chen X15, Tang H16, Sheng J17, Lu F18, Jia J19, Zhuang H18, Xia N2, Hou J20; Chronic Hepatitis B Study Consortium; Chronic Hepatitis B Study Consortium. Gut. 2015 Jan 13. pii: gutjnl-2014-308546. doi: 10.1136/gutjnl-2014-308546. [Epub ahead of print] |
|
| |
| 538. | Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled Trial |
| |
Qu C1, Chen T2, Fan C2, Zhan Q1, Wang Y1, Lu J2, Lu LL2, Ni Z2, Huang F2, Yao H2, Zhu J2, Fan J2, Zhu Y2, Wu Z1, Liu G1, Gao W1, Zang M1, Wang D1, Dai M3, Hsia CC1, Zhang Y4, Sun Z1. PLoS Med. 2014 Dec 30;11(12):e1001774. doi: 10.1371/journal.pmed.1001774. eCollection 2014. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 557. | Tenofovir Disoproxil Fumarate in Asian or Pacific Islander Chronic Hepatitis B Patients With High Viral Load (? 9 log10 copies/mL) |
| |
Fung S1, Gordon SC, Krastev Z, Horban A, Petersen J, Sperl J, Gane E, Jacobson IM, Yee LJ, Dinh P, Martins EB, Flaherty JF, Kitrinos KM, Dusheiko G, Trinh H, Flisiak R, Rustgi VK, Buti M, Marcellin P. Liver Int. 2014 Oct 2. doi: 10.1111/liv.12694. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 561. | Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women |
| |
Lu LL1, Chen BX2, Wang J3, Wang D4, Ji Y4, Yi HG4, Chen T4, Zhang Y5, Petersen E6, Li Q7, Qu C8. Int J Infect Dis. 2014 Sep 19. pii: S1201-9712(14)01613-0. doi: 10.1016/j.ijid.2014.07.028. [Epub ahead of print] |
|
| |
| 562. | Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial |
| |
Hou JL1, Gao ZL, Xie Q, Zhang JM, Sheng JF, Cheng J, Chen CW, Mao Q, Zhao W, Ren H, Tan DM, Niu JQ, Chen SJ, Pan C, Tang H, Wang H, Mao YM, Jia JD, Ning Q, Xu M, Wu SM, Li J, Zhang XX, Ji Y, Dong J, Li J. J Viral Hepat. 2014 Sep 22. doi: 10.1111/jvh.12313. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 568. | Scoring systems for predicting mortality after liver transplantation |
| |
Pan HC1, Jenq CC2, Lee WC3, Tsai MH4, Fan PC1, Chang CH1, Chang MY2, Tian YC2, Hung CC2, Fang JT2, Yang CW2, Chen YC2. PLoS One. 2014 Sep 12;9(9):e107138. doi: 10.1371/journal.pone.0107138. eCollection 2014. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 574. | A Randomized, Open-Label Clinical Study of Combined Peginterferon Alfa-2a (40KD) and Entecavir Treatment for HBeAg-Positive Chronic Hepatitis B |
| |
Xie Q1, Zhou H1, Bai X2, Wu S3, Chen JJ4, Sheng J5, Xie Y6, Chen C7, Chan HL8, Zhao M9. Clin Infect Dis. 2014 Sep 4. pii: ciu702. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 585. | Efficacy of Entecavir plus Tenofovir Combination Therapy for Chronic Hepatitis B Patients with Multi-Drug Resistant Strains |
| |
Lee YB1, Lee JH2, Lee DH1, Cho H1, Ahn H1, Choi WM1, Cho YY1, Lee M1, Yoo JJ1, Cho Y1, Cho EJ1, Yu SJ1, Kim YJ1, Yoon JH1, Kim CY1, Lee HS1. Antimicrob Agents Chemother. 2014 Aug 25. pii: AAC.03845-14. [Epub ahead of print] |
|
| |
| 586. | Entecavir Is Safe and Effective in Patients Previously Treated with Adefovir, including Those with Adefovir-Resistance |
| |
Nguyen NH1, Trinh HN, Nguyen TT, Do ST, Tran P, Nguyen HA, Nguyen KK, Garcia RT, Lutchman GA, Nguyen MH. J Gastroenterol Hepatol. 2014 Aug 28. doi: 10.1111/jgh.12728. [Epub ahead of print] |
|
| |
| 587. | Assessment of Bone Mineral Density in Tenofovir treated Chronic Hepatitis B patients: Can FRAX identify those at greatest risk? |
| |
Gill US1, Zissimopoulos A2, Al-Shamma S2, Burke K2, McPhail MJ3, Barr DA4, Kallis YN2, Marley RT2, Kooner P2, Foster GR1, Kennedy PT1. J Infect Dis. 2014 Aug 25. pii: jiu471. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 590. | Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B was associated with unexpected high rate of peripheral neuropathy |
| |
Marcellin P1, Wursthorn K2, Wedemeyer H2, Chuang WL3, Lau G4, Avila C5, Peng CY6, Gane E7, Gee Lim S8, Fainboim H9, Foster GR10, Safadi R11, Rizzetto M12, Manns M2, Bao W13, Naoumov N5. J Hepatol. 2014 Aug 21. pii: S0168-8278(14)00607-2. doi: 10.1016/j.jhep.2014.08.021. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 603. | Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B |
| |
Brouwer WP1, Sonneveld MJ, Tabak F, Simon K, Cakaloglu Y, Akarca US, Zeuzem S, Ferenci P, Heathcote JE, de Knegt RJ, Boonstra A, Hansen BE, Janssen HL. Aliment Pharmacol Ther. 2014 Aug 11. doi: 10.1111/apt.12910. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 608. | Understanding early serum hepatitis D virus and HBsAg kinetics during pegylated interferon-alfa therapy via mathematical modeling |
| |
Guedj J1, Rotman Y, Cotler SJ, Koh C, Schmid P, Albrecht J, Haynes-Williams V, Liang JT, Hoofnagle JH, Heller T, Dahari H. Hepatology. 2014 Aug 7. doi: 10.1002/hep.27357. [Epub ahead of print] |
|
| |
| 609. | A Randomized Study to Evaluate the Immunogenicity and Safety of a Heptavalent Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus influenzae b, and Meningococcal Serogroup C Combination Vaccine Administered to Infants at 2, 4, and 12 Months of Age |
| |
Thollot F1, Scheifele D, Pankow-Culot H, Cheuvart B, Leyssen M, Ulianov L, Miller JM. Pediatr Infect Dis J. 2014 Jul 16. [Epub ahead of print] |
|
| |
|
|
| |
| 611. | Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate |
| |
Marcellin P1, Buti M2, Krastev Z3, de Man RA4, Zeuzem S5, Lou L6, Gaggar A6, Flaherty JF6, Massetto B6, Lin L6, Dinh P6, Mani Subramanian G6, McHutchison JG6, Flisiak R7, Gurel S8, Dusheiko GM9, Jenny Heathcote E10. J Hepatol. 2014 Jul 18. pii: S0168-8278(14)00518-2. doi: 10.1016/j.jhep.2014.07.019. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 623. | Residual Amount of HBV DNA in Serum is Related to Relapse in Chronic Hepatitis B Patients After Cessation of Nucleos(t)ide Analogs |
| |
Jiang JN1, Huang ZL, He LX, Huang YH, Su MH, Xie R, Liang YX, Fu WD, Huang XH, Guo WW, Zhong SH, Liu ZH, Li SH, Zhu TF, Gao ZL. J Clin Gastroenterol. 2014 Jul 10. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 626. | Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest) and elastography (FibroScan) |
| |
Poynard T1, Vergniol J2, Ngo Y3, Foucher J2, Thibault V4, Munteanu M3, Merrouche W2, Lebray P5, Rudler M5, Deckmyn O3, Perazzo H5, Thabut D5, Ratziu V5, de Ledinghen V2. J Hepatol. 2014 Jul 9. pii: S0168-8278(14)00457-7. doi: 10.1016/j.jhep.2014.06.027. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 629. | Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians |
| |
Arends P1, Sonneveld MJ1, Zoutendijk R1, Carey I2, Brown A3, Fasano M4, Mutimer D5, Deterding K6, Reijnders JG1, Oo Y5, Petersen J7, van Bömmel F8, de Knegt RJ1, Santantonio T4, Berg T8, Welzel TM9, Wedemeyer H6, Buti M10, Pradat P11, Zoulim F11, Hansen B1, Janssen HL12; for the VIRGIL Surveillance Study Group. Gut. 2014 Jul 10. pii: gutjnl-2014-307023. doi: 10.1136/gutjnl-2014-307023. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 635. | Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer |
| |
Levaggi A1, DE Maria A2, Dozin B3, Iacono G4, Bighin C5, Giraudi S4, Lambertini M5, D'Alonzo A4, Poggio F5, Pronzato P5, Del Mastro L4. Anticancer Res. 2014 Jul;34(7):3715-20. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 653. | Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of Hepatitis B Virus |
| |
Greenup AJ1, Tan PK1, Nguyen V1, Glass A1, Davison S1, Chatterjee U2, Holdaway S3, Samarasinghe D3, Jackson K4, Locarnini S4, Levy MT5. J Hepatol. 2014 May 3. pii: S0168-8278(14)00301-8. doi: 10.1016/j.jhep.2014.04.038. [Epub ahead of print] |
|
| |
|
|
| |
| 655. | Early identification and linkage to care of persons with chronic hepatitis B virus infection - three u.s. Sites, 2012-2014 |
| |
Beckett GA, Ramirez G, Vanderhoff A, Nichols K, Chute SM, Wyles DL, Schoenbachler BT, Bedell DT, Cabra R, Ward JW; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC. MMWR Morb Mortal Wkly Rep. 2014 May 9;63(18):399-401. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 663. | Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease |
| |
Pang JX1, Zimmer S2, Niu S2, Crotty P3, Tracey J3, Pradhan F3, Shaheen AA3, Coffin CS3, Heitman SJ1, Kaplan GG1, Swain MG3, Myers RP1. PLoS One. 2014 Apr 22;9(4):e95776. doi: 10.1371/journal.pone.0095776. eCollection 2014. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 675. | Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007 |
| |
Byrne DD1, Newcomb CW2, Carbonari DM3, Nezamzadeh MS3, Leidl KB2, Herlim M2, Yang YX4, Hennessy S3, Kostman JR5, Leonard MB6, Localio R2, Lo Re V 3rd7. Ann Epidemiol. 2014 Mar 5. pii: S1047-2797(14)00075-1. doi: 10.1016/j.annepidem.2014.02.013. [Epub ahead of print] |
|
| |
| 676. | Risk of Hip Fracture Associated with Untreated and Treated Chronic Hepatitis B Virus Infection |
| |
Byrne DD1, Newcomb CW2, Carbonari DM3, Nezamzadeh MS3, Leidl KB2, Herlim M2, Yang YX1, Hennessy S3, Kostman JR4, Leonard MB5, Russell Localio A2, Lo Re V 3rd6. J Hepatol. 2014 Apr 5. pii: S0168-8278(14)00218-9. doi: 10.1016/j.jhep.2014.04.001. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 679. | Hepatitis B in pregnancy |
| |
Dyson JK1, Waller J2, Turley A3, Michael E3, Moses S4, Valappil M4, Hudson M5, Bassendine M5, McPherson S5. Frontline Gastroenterol. 2014 Apr;5(2):111-117. Epub 2013 Oct 17. |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 683. | Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region |
| |
Bottero J1, Boyd A2, Lemoine M3, Carrat F4, Gozlan J5, Collignon A6, Boo N7, Dhotte P8, Varsat B9, Muller G10, Cha O11, Valin N12, Nau J13, Campa P12, Silbermann B14, Bary M15, Girard PM1, Lacombe K1. PLoS One. 2014 Mar 24;9(3):e92266. doi: 10.1371/journal.pone.0092266. eCollection 2014. |
|
| |
|
|
| |
| 685. | The importance of baseline viral load when assessing relative efficacy in treatment-naive HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis |
| |
Mealing S, Ghement I, Hawkins N, Scott DA, Lescrauwaet B, Watt M, Thursz M, Lampertico P, Mantovani L, Morais E, Bregman B, Cucherat M. Syst Rev. 2014 Mar 7;3(1):21. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 689. | Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009 |
| |
Zhou F1, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A, Moore M, Murphy TV, Cortese M, Rodewald L. Pediatrics. 2014 Mar 3. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 695. | Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD-EEG |
| |
Montagnese S, De Rui M, Schiff S, Ceranto E, Valenti P, Angeli P, Cillo U, Zanus G, Gatta A, Amodio P, Merkel C. Liver Int. 2014 Feb 12. doi: 10.1111/liv.12490. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
| 698. | Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients with Normal Levels of Alanine Aminotransferase and High Levels of HBV DNA |
| |
Chan HL1, Chan CK2, Hui AJ3, Chan S4, Poordad F5, Chang TT6, Mathurin P7, Flaherty JF8, Lin L8, Corsa A8, Gaggar A8, Subramanian GM8, McHutchison JG8, Lee S9, Gane EJ10. Gastroenterology. 2014 Jan 23. pii: S0016-5085(14)00103-6. doi: 10.1053/j.gastro.2014.01.044. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 705. | Biomarkers of liver cell deat. |
| |
Eguchi A1, Wree A2, Feldstein AE2. J Hepatol. 2014 Jan 8. pii: S0168-8278(14)00006-3. doi: 10.1016/j.jhep.2013.12.026. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 710. | Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals |
| |
Godbole G, Irish D, Basarab M, Mahungu T, Fox-Lewis A, Thorne C, Jacobs M, Dusheiko G, Rosenberg WM, Suri D, Millar AD, Nastouli E. BMC Pregnancy Childbirth. 2013 Dec 1;13:222. doi: 10.1186/1471-2393-13-222. |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 714. | Long-term efficacy and safety of emtricitabine plus tenofovir DF vs tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients |
| |
Berg T, Zoulim F, Moeller B, Trinh H, Marcellin P, Chan S, Kitrinos KM, Dinh P, Flaherty Jr JF, McHutchison JG, Manns M. J Hepatol. 2013 Nov 29. pii: S0168-8278(13)00826-X. doi: 10.1016/j.jhep.2013.11.024. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 721. | Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma |
| |
Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Batrla-Utermann R, Wang LY, You SL, Hsiao CK, Chen PJ, Chen CJ; for the R.E.V.E.A.L.-HBV Study Group. Gut. 2013 Nov 13. doi: 10.1136/gutjnl-2013-305785. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 736. | Anti-TNF therapy in patients with HBV infection-analysis of 87 patients with inflammatory arthritis |
| |
Ye H, Zhang XW, Mu R, Fang LK, Gu JR, Lin J, Du JF, Chen JW, Chen YJ, Wu LJ, Pang XF, Li ZG. Clin Rheumatol. 2013 Sep 29. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 741. | High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients |
| |
Yu ML, Dai CY, Huang CF, Lee JJ, Yeh ML, Yeh SM, Kuo HT, Huang JF, Chang JM, Chen HC, Juo SH, Hwang SJ, Chuang WL; FORMOSA-LIKE group. J Hepatol. 2013 Oct 2. pii: S0168-8278(13)00683-1. doi: 10.1016/j.jhep.2013.09.023. [Epub ahead of print] |
|
| |
|
|
| |
| 743. | Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population |
| |
Gordon SC, Lamerato LE, Rupp LB, Li J, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Vijayadeva V, Boscarino JA, Henkle EM, Oja-Tebbe N, Lu M; Checs Investigators. Clin Gastroenterol Hepatol. 2013 Oct 6. pii: S1542-3565(13)01511-5. doi: 10.1016/j.cgh.2013.09.062. [Epub ahead of print] |
|
| |
|
|
| |
| 745. | Efficacy of adefovir-based combination therapy for patients with Lamivudine- and entecavir-resistant chronic hepatitis B virus infection |
| |
Lee YB, Lee JH, Choi WM, Cho YY, Yoo JJ, Lee M, Lee DH, Cho Y, Yu SJ, Kim YJ, Yoon JH, Kim CY, Lee HS. Antimicrob Agents Chemother. 2013 Dec;57(12):6325-32. doi: 10.1128/AAC.01742-13. Epub 2013 Oct 7. |
|
| |
|
|
| |
| 747. | Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial |
| |
Pande C, Sarin SK, Patra S, Kumar A, Mishra S, Srivastava S, Bhutia K, Gupta E, Mukhopadhyay CK, Dutta AK, Trivedi SS. J Viral Hepat. 2013 Nov;20(11):801-10. doi: 10.1111/jvh.12102. Epub 2013 Apr 23. |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 751. | Compromised Function of Natural Killer Cells in Acute and Chronic Viral Hepatitis |
| |
Lunemann S, Malone DF, Hengst J, Port K, Grabowski J, Deterding K, Markova A, Bremer B, Schlaphoff V, Cornberg M, Manns MP, Sandberg JK, Ljunggren HG, Björkström NK, Wedemeyer H. J Infect Dis. 2013 Nov 1. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 757. | Analysis of S gene mutation of the hepatitis B virus in adult liver transplant recipients showing resistance to hepatitis B immunoglobulin therapy |
| |
Park GC, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Shin YW, Kim SH, Chang KH, Namgoong JM, Park CS, Park HW, Park YH, Kang SH, Jung BH, Lee SG. Transplant Proc. 2013 Oct;45(8):3047-51. doi: 10.1016/j.transproceed.2013.08.055. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 764. | Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population |
| |
Gordon SC, Lamerato LE, Rupp LB, Li J, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Vijayadeva V, Boscarino JA, Henkle EM, Oja-Tebbe N, Lu M; Checs Investigators. Clin Gastroenterol Hepatol. 2013 Oct 6. pii: S1542-3565(13)01511-5. doi: 10.1016/j.cgh.2013.09.062. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 770. | IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients |
| |
Zhang Q, Lapalus M, Asselah T, Laouénan C, Moucari R, Martinot-Peignoux M, Bieche I, Estrabaud E, De Muynck S, Boyer N, Bedossa P, Vidaud M, Marcellin P, Lada O. J Viral Hepat. 2013 Oct 10. doi: 10.1111/jvh.12177. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 776. | Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis |
| |
Akuta N, Suzuki F, Kobayashi M, Hara T, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Saitoh S, Ikeda K, Kumada H. J Med Virol. 2014 Jan;86(1):131-8. doi: 10.1002/jmv.23790. Epub 2013 Oct 12. |
|
| |
| 777. | De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis |
| |
Lian JS, Zeng LY, Chen JY, Jia HY, Zhang YM, Xiang DR, Yu L, Hu JH, Lu YF, Zheng L, Li LJ, Yang YD. World J Gastroenterol. 2013 Oct 7;19(37):6278-83. doi: 10.3748/wjg.v19.i37.6278. |
|
| |
| 778. | De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis |
| |
Lian JS, Zeng LY, Chen JY, Jia HY, Zhang YM, Xiang DR, Yu L, Hu JH, Lu YF, Zheng L, Li LJ, Yang YD. World J Gastroenterol. 2013 Oct 7;19(37):6278-83. doi: 10.3748/wjg.v19.i37.6278. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| | | | |
